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ABSTRACT 
Objective: The purpose of this study was to explore the relationships between dietary intake of 
vitamin K, vitamin A, vitamin D, fiber, and bone mineral density in a sample of pre-menarcheal 
female gymnasts and non-gymnasts in the Syracuse-area. The goal was to observe whether 
higher intakes of these vitamins were associated with higher bone mineral density as measured 
by dual-energy X-ray absorptiometry (DXA), and to potentially examine the impact of activity 
level on these relationships. 
 
Methods: A cross-sectional design was used to examine a subset of data from a larger on-going 
longitudinal study on bone growth and physical activity in young females. The original study 
was designed to compare activity, and bone density data between gymnast and non-gymnasts. 
The data used in this analysis were collected from January 2009 to September 2012 from 52 pre-
menarcheal female gymnasts and non-gymnasts between the ages of 9-11. Participants were 
asked to complete Harvard’s Youth/Adolescent Questionnaire biannually to quantify nutrient 
intake. Annual bone density measurements were taken of the lumbar spine and total body using 
dual-energy X-ray absorptiometry (DXA). Participants also were asked to self-report physical 
activity semi-annually during an interview session in which they described the type of activity 
and hours per week of participation. Tanner breast and pubic stages were self-assessed by 
subjects at each interview session. Standing height, sitting height, and weight measures were 
collected at the interview sessions as well. 
 
Participants: The participants were 52 pre-menarcheal female gymnasts and non-gymnasts 
between the ages of 9-11. The selection criteria for this analysis was limited to participants who 
 
 
 
 
self-reported as Tanner Stage I (Tanner breast I and Tanner pubic I) at the time of the annual 
DXA scan. This criterion minimizes the potentially confounding effects of estrogen on bone 
density and mineral concentration. Non-Caucasian subjects were not included in this analysis as 
the original cohort of subjects were predominantly Caucasian and the sample size for the current 
study was too small to account for racial variation. A factor analysis was performed to decrease 
the dimensionality of the full data set. A principle component analysis was used to observe 
groupings of dietary variables and to better understand over all dietary patterns. Pearson 
correlations, and simple linear regressions were used to identify associations between specific 
micronutrients and minerals and bone mineral density. Multiple regression analyses and 
ANOVA (general linear model, GLM) were used to further examine the relationships 
relationship between bone mineral density and the intake of vitamin A, vitamin D, biologically 
active vitamin K, and the ratio of vitamin A:D intake while adjusting for physical activity, 
weight, and age of participants. Statistical significance for all tests was set at the α=0.05 level. 
  
Results: Inverse relationships were found between bone mineral density and dietary intake of 
vitamin A (p=0.018), beta-carotene (p=0.008), fiber (p=0.029), and carotene (p=0.007). Bone 
mineral density increased with a combination of increased vitamin K1 intake and increased body 
mass (p=0.0006) and vitamin A and increased body mass (p=0.0001). A complex relationship 
appears to exist between bone mineral density and the combination of vitamin A and vitamin D 
intakes. The lowest bone mineral densities were observed in the highest quartile of vitamin A 
intake; this quartile was well above the tolerable upper limit for the age range of the focal 
population age range. The lowest bone densities were also associated with the highest levels of 
vitamin D, which was an unexpected result. However, this quartile of vitamin D intake was also 
 
 
 
 
above daily recommend intake levels for the focal population. Although not statistically 
significant, bone mineral density was lowest when vitamin A was either very high (4th quartile 
of vitamin A intake, mean ± stdev = 17,317.34 ±4358.86 IU) or very low (1st quartile of vitamin 
A intake, mean ± stdev = 5243.01 ±1230.68 IU) with respect to vitamin D intake. Intermediate 
levels of the ratio of the vitamin A intake with reference to vitamin D intake produced the 
highest bone densities. 
 
Conclusions: Higher intakes of fiber, vitamin A, carotene, and beta-carotene appear to be 
associated with lower measures of bone mineral density in this study population. Increased 
difference in the intake of vitamin A with respect to vitamin D appears to be associated with 
lower measures of bone mineral density, even with intake levels of vitamin D above the EAR 
and RDA suggested for this age group. This relationship may result from excess preformed 
vitamin A ingestion leading to increased retinoic acid in the body. Excess retinoic acid has the 
potential to impair vitamin D’s ability to carry out its own genomic functions. These 
relationships warrant further exploration in order to improve the understanding of the genomic 
impact of vitamin A’s impact on bone metabolism in the preadolescent life stages, as well as to 
aid in the prevention of negative effects on bone mineral density during this time period. 
 
 
 
 
 
 
 
 
 
 
 
 
EXPLORING DIETARY INTAKES OF MICRONUTRIENTS INVOLVED IN BONE 
REMODELING IN RELATION TO BONE MINERAL DENSITY AND PHYSICAL 
ACTIVITY LEVELS: 
AN EXAMINATION OF PRE-MENARCHEAL FEMALE GYMNASTS AND NON-
GYMNASTS. 
 
 
 
BY 
 
Sarah Skinner 
B.S., University of Rochester, 2014 
 
 
Master’s Thesis 
Submitted in partial fulfillment of the requirements for the degree of 
Master of Science in Nutrition Science 
 
 
Syracuse University 
May 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Sarah Skinner 2016 
All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
ACKNOWLEDGMENTS 
 
I would like to first thank my advisor, Dr. Margaret Voss, for providing me with a great deal 
of support and encouragement that have allowed me to get through this process. Thank 
you for always believing in me, and for helping me to discover my passion for research and 
teaching. 
 
I would also like to thank Dr. Lynn Brann and Dr. Jodi Dowthwaite, for providing valuable 
feedback and direction while serving on my proposal and thesis defense committees. 
 
Finally, I would like to thank Mom, Dad, Kristen, Matt, and Shawn, whose constant support 
and endless encouragement have allowed me to follow my dreams and find my true 
passion. I truly would not have been able to do any of this without all of you. 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
TABLE OF CONTENTS 
 
LIST OF FIGURES .................................................................................................................. viii 
Part I: Literature Review and Proposed Study Design ............................................................. 1 
Introduction .......................................................................................................................... 1 
Physical Activity, Bone Growth, and Remodeling ............................................................................1 
Mineral Metabolism and Calcium ...................................................................................................4 
The Role of Vitamin K in Mineral Metabolism .................................................................................6 
Vitamin K Regulation of RANK Expression and Osteoclast Activity ................................................. 13 
Study Objectives .................................................................................................................. 14 
Methods ............................................................................................................................. 15 
Study Design ................................................................................................................................ 15 
Participant Recruitment/Demographics ........................................................................................ 15 
Statistical Analysis ....................................................................................................................... 18 
Part II: Thesis Manuscript .................................................................................................... 19 
Introduction ................................................................................................................................ 19 
Data Reduction and Statistical Analysis ........................................................................................ 20 
Results ......................................................................................................................................... 23 
Discussion .................................................................................................................................... 33 
Conclusion ................................................................................................................................... 44 
Appendix A .......................................................................................................................... 46 
Appendix B .......................................................................................................................... 58 
Appendix C  ......................................................................................................................... 59 
Appendix D ......................................................................................................................... 63 
Appendix E .......................................................................................................................... 70 
Appendix F .......................................................................................................................... 73 
Appendix G ......................................................................................................................... 76 
References .......................................................................................................................... 77 
Vita ..................................................................................................................................... 81 
 
 
 
 
 
 
viii 
 
 
 
LIST OF FIGURES 
 
 
FIGURE 1. Endocrine regulation of serum calcium levels showing the actions of PTH and 
calcitriol on their respective organ targets ............................................................................... 5 
FIGURE 2. Structures of phylloquinone, menaquinone-4, menaquinone-7, and menadione
 ......................................................................................................... Error! Bookmark not defined. 
FIGURE 3: Graphical representation of component 3 vs component 1 vs component 2 from 
principal component analysis with labeled groupings ............................................... 23 
FIGURE 4. Bone mineral density as a function of biologically active vitamin K intake. ........ 26 
FIGURE 5. Change in BMD from beginning of study participation to most recent DXA scan 
as a function of the most recently reported vitamin A intake, when adjusted for age 
and physical activity ..................................................................................................................... 26 
FIGURE 6. Change in BMD from beginning of study participation to most recent DXA scan 
vs change in weight from first measurement to most recent measurement, when 
adjusted for age and physical activity ...................................................................................... 27 
FIGURE 7. BMD as a function of the most recently reported intake of vitamin D, with 
respect to change in weight ........................................................................................................ 27 
FIGURE 8. Change in BMD from beginning of study participation to most recent DXA scan 
as a function of the most recently reported intake of vitamin D, with respect to change 
in weight ......................................................................................................................................... 28 
FIGURE 9. Vitamin A intake levels as separated by quartile of intake for all subjects .......... 29 
FIGURE 10. Bone mineral density (g cm−3) as a function of vitamin A (IU) intake in a 
population of pre-adolescent girls ............................................................................................ 29 
FIGURE 11. Vitamin D intake levels as separated by quartile of intake for all subjects ....... 30 
FIGURE 12. Bone mineral density (g cm−3) as a function of the difference between vitamin 
A (IU) to vitamin D (IU) intake in a population of pre-adolescent girls ........................... 31 
 
 
 
 
 
 
 
1 
 
 
 
Part I: Literature Review and Proposed Study Design 
Introduction 
The purpose of this study is to explore the relationships between dietary intake of foods 
rich in vitamin K1, calcium, vitamin A, vitamin D and bone density in young female gymnasts 
and a comparison group of active non-gymnasts. We would like to determine if higher levels of 
vitamin intake in young females are associated with higher levels of bone density. 
 
Physical Activity, Bone Growth, and Remodeling 
 Skeletal growth in adolescence is characterized by the synthesis of new bone through 
endochondral ossification as well as the modeling and remodeling of existing bone.1 It has been 
well-documented that significant bone adaptations and remodeling occur following the 
introduction of high-intensity weight-bearing activities during childhood, and growing bone 
possesses a greater capability to adapt to mechanical loading.2 It has also been postulated that the 
skeletal benefits that are acquired during this period of growth are able to be retained to some 
extent, potentially aiding in the prevention of fractures later in life.3 Therefore, we are interested 
in further exploring the associations between physical activity levels and changes in bone 
parameters over time in pre-pubescent females. In particular, we are interested in females 
participating in artistic gymnastics; there is a vast body of work that indicates that participation 
in high-impact activities such as artistic gymnastics significantly increases skeletal growth in 
pre-pubertal girls. There is also evidence that these young gymnasts tend to display higher levels 
of bone mineral content (BMC) and bone mineral density (BMD) than their non-gymnast peers, 
potentially allowing for a greater protective effect against fractures later in life.4 This evidence is 
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consistent with the knowledge that exercise involving heavy impact and frequent mechanical 
loading is able to trigger the bone remodeling process, leading to changes in bone structure and 
increased BMC and BMD.5  
 Bone modeling and remodeling are processes that are central to the development and 
maintenance of the skeletal system. Remodeling involves the constant removal of packets of old 
bone and then immediately replacing this area with new bone through mineralization of the 
matrix, therefore preventing bone microdamage from accumulating and causing significant 
damage.6 Osteoclasts and osteoblasts are at the core of this process, with the former responsible 
for the removal of old bone and the latter involved in the formation of new bone. Osteoclasts are 
the only known cells capable of resorbing bone. They are derived from mononuclear monocyte-
macrophage precursor cells, and their formation is dependent on receptor activation of NF-κβ 
ligand (RANKL) and macrophage CSF (M-CSF) cytokine.6 Activated osteoclasts carry out their 
required duty by binding to bone matrix and releasing acidified vesicles to the bone resorption 
surface that break down one particular region, with the surrounding bone surface protected 
through a simultaneous mechanism that seals off the resorption area.  
 In contrast, osteoblast activity involves the synthesis and calcification of bone matrix to 
create new bone.7 These cells are derived from osteoprogenitor cells that arise from pluripotent 
stem cells, and are responsible for the deposition of bone matrix in intramembraneous and 
endochondral bone formation.8 The third major cell type involved in bone remodeling is the 
osteocyte. These cells are former osteoblasts that become trapped during bone deposition and 
thus become part of the mineralized bone matrix.9 In recent years, an increasing body of 
evidence has implicated osteocytes as being primarily responsible for bone’s adaptation to 
mechanical forces placed upon it, but the molecular mechanisms have yet to be elucidated. 
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Additionally, osteocytes have been found to be regulators of osteoblast and osteoclast production 
and function, giving them a critical role in the bone remodeling cycle.  
 A multitude of dietary components also come in to play when dealing with bone mineral 
density, bone mineral concentration, and the process of bone remodeling; calcium, vitamin D, 
vitamin A, vitamin K, and the omega-3 fatty acids have been found to be of particular 
significance. In brief, vitamin D has been found to play an important role in stimulating 
osteoblastogenesis in mesenchymal stem cells as well as affecting bone mineralization through 
its function in intestinal calcium absorption and bone mineral accretion.10 Calcium’s relationship 
to bone health has been extensively researched, and increased calcium intake has been strongly 
associated with increased bone accrual, as well as decreased parathyroid hormone (PTH) levels 
and decreased bone resorption.11  
Vitamin A’s role in bone health is less clear, but is known to be involved due to nuclear 
receptors for retinoic acid in osteoblasts and osteoclasts.12 Some studies have proposed that 
increasing vitamin A intake may decrease BMD and promote fractures, while others have not 
shown any increase in bone loss or fracture risk, and still others have suggested that increased 
vitamin A intake may be protective from bone loss.13 Therefore, extensive research is still 
required to create a clearer picture of where vitamin A fits in to the bone remodeling process as 
well as to determine what forms of vitamin A have the greatest impact. Omega-3 fatty acids have 
been more recently linked to the bone remodeling process, as recent human studies have reported 
long-chain polyunsaturated fatty acids (LCPUFAs) increasing bone formation, leading to a 
positive effect on peak bone mass and reducing bone loss in adolescents.14 The exact mechanism 
of how these LCPUFAs can act on bone remodeling is still being investigated, but is postulated 
to be related to their role in the release of the receptor-activated nuclear factor-κβ ligand 
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(RANKL), which is involved in the differentiation of osteoclasts in osteoclast precursors.15 
Finally, vitamin K has a well-established connection to bone health as it is a necessary cofactor 
for the gamma-carboxylation of osteocalcin, a noncollagenous bone protein produced by 
osteoblasts that is used as a biomarker for bone formation.12 Additionally, epidemiological 
studies have shown an association between low vitamin K intake and lower BMD, although 
randomized controlled trials have shown conflicting results as well as have suggested differences 
in the function of vitamin K1 (phylloquinone) and vitamin K2 (menaquinones) in regards to bone 
health.  
 
Mineral Metabolism and Calcium 
Calcium homeostasis plays a key role in multiple skeletal and cellular processes in the 
human body, and therefore is tightly controlled. Dietary calcium is absorbed across the intestinal 
epithelial brush border primarily through the calcium channel TRPV6, while a smaller amount is 
able to be absorbed through paracellular diffusion. Once inside the cell, calcium is bound to 
transport protein calbindin for transportation to the endoplasmic reticulum and then to the 
basolateral membrane of the cell.16 Calcium is then able to enter the bloodstream through use of 
a Ca2+-ATPase pump, allowing it to circulate throughout the body.17 Serum calcium levels are 
regulated to remain between 8.5 to 10.5 mg/dL by an endocrine system involving multiple 
feedback systems and use of vitamin D metabolites such as calcitriol and parathyroid hormone 
(PTH). If levels are too low, the parathyroid gland is signaled to secrete more PTH, which is then 
able to signal for increased bone resorption to increase serum calcium levels. PTH also acts to 
stimulate the kidneys to produce more calcitriol and decrease urinary calcium excretion. The 
calcitriol produced by the kidneys signals to the epithelial cells of the small intestine to increase 
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calcium absorption, further leading to increased serum calcium levels.17 A feedback mechanism 
is then employed; as serum calcium levels increase to the normal range, PTH secretion decreases 
leading to decreased calcitriol production, slowed bone resorption, and the intestinal cells resume 
normal calcium absorption. If serum calcium levels are too high, the parathyroid gland is 
signaled to secrete less PTH. This leads to a decrease in calcitriol production and increased 
calcium excretion by the kidneys. The thyroid gland is also involved, as its “c” cells are signaled 
to release the peptide hormone calcitonin to halt bone resorption through inhibiting the activity 
of the osteoclast cells that release calcium from the bone.17 A feedback mechanism is again 
employed to halt these responses as serum calcium levels decrease in order to maintain the 
narrow normal serum calcium range. The following diagram shows the endocrine regulation 
pathway in the case of hypocalcemia.  
 
Figure 1: Endocrine regulation of serum calcium levels showing the actions of PTH and 
calcitriol on their respective organ targets. Note: PTG=Parathyroid gland; CT= Calcitonin. From 
Ross et al., 2011.16  
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The Role of Vitamin K in Mineral Metabolism 
The group of K vitamins was first discovered by the Danish biochemist Henrik Dam in 
1929 while conducting research on the use of fat-free diets in chicks. Dam observed that the 
chicks consuming the fat-free diet developed hemorrhages under the skin and muscle that could 
not be cured through use of vitamin C, A, or D supplementation, and he and his group 
determined that the delayed blood coagulation was the result of an absence of prothrombin 
activity in the plasma.18 This led to the subsequent discovery of the fat-soluble vitamin K 
structure and the first hint at its role in the coagulation cascade. All compounds with vitamin K 
activity share a common 2-methyl-1,4-napthoquinone ring and are differentiated by their 
structure at the 3-position. Figure 2 below depicts the structures of vitamin K1, two forms of 
vitamin K2, and the synthetic vitamin K3. The most common form of vitamin K is vitamin K1, 
or phylloquinone, which has a phytyl substituent at the 3-position, and is most commonly found 
in green, leafy vegetables. Vitamin K2 consists of a group of vitamin K structures with a varying 
number of isoprenyl side chain units, known as menaquinones. The most common menaquinones 
are MK-4 and MK-7, which are primarily obtained in the diet through low amounts found in 
animal products such as meat, eggs, liver, and cheeses, as well as much higher amounts present 
in fermented foods.19  
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Figure 2: Structures of phylloquinone, menaquinone-4, menaquinone-7, and 
menadione. From Shea et al., 2016.20 
Forty years after Dam’s group determined its existence, the mechanism of action of 
vitamin K was elucidated following the discovery of γ-carboxyglutamic acid (Gla) in 1974, 
which explained the prolonged prothrombin time observed in vitamin K deficiencies and led to 
the discovery of more vitamin K-dependent proteins (VKDPs). The currently known VKDPs 
include blood coagulation proteins such as prothrombin, factors VII, IX, X, protein C, protein S, 
and protein Z, and bone Gla proteins osteocalcin, MGP, and protein S. The blood coagulation 
VKDPs contain 10-12 Gla residues that enable Ca2+-mediated binding of the proteins to 
negatively charged phospholipid surfaces of platelets and endothelial cells at a site of injury in 
vascular tissue, subsequently allowing the factor proteins to carry out their role in the blood 
clotting cascade.18 This is traditionally the best known role of vitamin K; a cofactor in the 
carboxylation of glutamic acid residues to γ -carboxyglutamic acid in precursor proteins, 
allowing for binding of Ca2+ and subsequent participation in the clotting cascade.21 However, 
this group of vitamins is becoming increasingly known for the essential role played during γ-
carboxylation of the VKDP osteocalcin found in osteoblasts. Carboxylated osteocalcin binds to 
hydroxyapatite in mineralized tissues, creating a link between vitamin K and bone health.22  
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There is a substantial body of research that has examined relationships between vitamin 
K1 and bone health in different populations; in particular, osteocalcin has been frequently 
examined as a link between vitamin K1 and bone metabolism. A large portion of this research 
consists of population-based studies examining phylloquinone intake and bone mineral density 
(BMD), but results of these studies have been inconsistent. One of the first of such studies that 
explored this relationship was a prospective cohort, the Nurses’ Health Study, which was 
conducted over a ten-year period and examined the effect of daily vitamin K intake on bone 
fragility indices. Data was obtained from three semi-quantitative food frequency questionnaires 
(FFQ) from 72,327 women, over a period of ten years; phylloquinone content of the foods on the 
FFQ was obtained from the USDA, and women were asked to report all hip fractures.23 
Feskanich et al reported that food items contributing most to the women’s dietary 
phylloquinone intake were iceberg lettuce, cooked spinach, cabbage, raw spinach, romaine, 
Brussels sprouts, and kale, and only 1-4% of participants reported receiving greater than 10µg/d 
of phylloquinones from supplementation. The risk of hip fracture was found to be inversely 
associated with the amount of lettuce consumed, when comparing data from those who reported 
eating one or more servings per day to those who reported eating one or fewer servings of lettuce 
per week. Additionally, it was found that women in quintiles 2-5 of phylloquinone intake had 
significantly lower age-adjusted relative risk of hip fracture than women in the lowest quintile, 
and the risk estimates did not change when other osteoporosis risk factors, such as vitamin D and 
calcium intake, were added to the model.23 The authors concluded that low intakes of vitamin K 
may increase the risk for hip fracture in women. 
 Similar results were found upon examination of a Framingham Heart Study cohort of 
elderly men and women with a mean age of 75 years old, there was no significant association 
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found between phylloquinone intake and BMD; lower phylloquinone intake was found to be 
associated with an increased risk for hip fracture, but this also may indicate poorer overall 
nutritional status as phylloquinones are primarily found in green, leafy vegetables.24 In the same 
study looking at a younger cohort with a mean age of 59, phylloquinone intake was found to be 
positively associated with BMD when examined cross-sectionally in women, but the same effect 
was not found in men. However, when this cohort was examined using a prospective analysis, 
there was no significant association between phylloquinone intake and BMD change over 5 
years.25  
There has been some examination of vitamin K1 intake and markers of bone formation in 
study samples more similar to ours in age and life stage, as Kalkwarf et al (2004) looked at 
vitamin K status and BMC in a study of 245 healthy girls aged 3-19 over a period of four years.26 
Phylloquinone intake was not found to be consistently associated with BMC or other bone 
turnover markers, but higher levels of plasma phylloquinone and lower percentage of 
undercarboxylated osteocalcin were found to be associated with lower bone resorption and 
formation. Additionally, plasma phylloquinone was found to have a statistically significant 
inverse relationship with osteocalcin concentrations. The authors of this study concluded that 
better vitamin K status was associated with decreased bone turnover in this study sample. 
However, they also acknowledged the need for randomized controlled trials examining the 
effects of phylloquinone supplementation on bone turnover in this age group to provide more 
conclusive evidence of vitamin K’s suggested benefits to bone. 
Similarly, a study by O’Connor et al (2007) examined the relationship between serum 
percentage of undercarboxylated osteocalcin (ucOC) and BMC in a study sample of 223 healthy 
girls aged 11-12 years.27 Serum percentage ucOC was not found to be associated with markers of 
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bone resorption, but was found to have a significant inverse relationship with BMC of the total 
body as well as lumbar spine after adjusting for potential cofounders such as vitamin D status. 
The authors thus concluded that better vitamin K status was associated with higher BMC, but not 
bone turnover, in this population. Once again, they also acknowledged the need for randomized 
phylloquinone supplementation trials in children in order to confirm these observations.  
There have also been a significant number of randomized controlled trials examining 
phylloquinone supplementation influence on bone loss, but few have shown significant evidence 
of protective effects. Sokoll et al (1997) examined the response of osteocalcin in healthy adult 
subjects to diets formulated to contain different amounts of phylloquinones, and found that just 
five days of dietary supplementation of an additional 320µg of phylloquinones reduced 
undercarboxylated osteocalcin levels of the participants by an average of 41% as compared to 
when the participants were consuming a mixed diet containing about 100 µg of 
phylloquinones.28 Undercarboxylated osteocalcin levels were found to rise significantly upon 
return to the lower-phylloquinone diet, suggesting a potential role for undercarboxylated 
osteocalcin as a sensitive marker for vitamin K1 status in the body. Braam et al (2003) examined 
the effects of three years of mineral and vitamin D supplementation and combined mineral, 
vitamin D, and vitamin K1 supplementation on bone density in postmenopausal women between 
the ages of 50 and 60. The results of the study indicated that the group of women receiving the 
K1 supplementation had significantly reduced bone loss of the femoral neck, but found no 
significant positive effects on bone density of the lumbar spine.29 The same group then examined 
phylloquinone supplementation in female endurance athletes over two years as that population 
frequently experiences low bone mass that leads to stress fractures. However, no beneficial 
effects on bone loss at the femoral neck were found with supplementation.30 A 2007 double-
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blind, placebo-controlled study by Bolton-Smith et al examined the effect of two years of 200 
microgram/day phylloquinone supplementation combined with vitamin D and calcium on the 
bone health of Scottish women over age 60; one group received a placebo, another received just 
200 micrograms/day phylloquinone, a third group received vitamin D and calcium, and the final 
group received phylloquinone, vitamin D, and calcium.31 BMD measurements of the ultradistal 
radius, mid radius, and femoral necks of the subjects were taken at baseline and every six months 
after for the duration of the study. Significant increases in BMD at the ultradistal radius sites and 
significant decreases in undercarboxylated osteocalcin were found in the group supplemented 
with calcium, vitamin D and phylloquinone, but no significant changes were found at the femoral 
neck in any group and there was significant bone mineral loss at the mid-distal radius across all 
groups. The results of this study were therefore inconclusive, and support a need for more 
randomized controlled studies examining phylloquinone supplementation on bone health. 
Finally, Booth et al (2008) examined the effects of supplementation of 500 micrograms/d 
phylloquinone plus calcium and vitamin D in 452 men and women ages 60-80 years old in a 
randomized, double-blind, controlled trial.32 Total-body BMD was measured, and measurements 
of the femoral neck, spine, and vitamins K and D status were measured every 6-12 months. No 
significant differences were found between the two groups in terms of BMD measurements at 
any site, while the group receiving phylloquinone supplementation presented a significant 
reduction in percentage of undercarboxylated osteocalcin. The authors concluded that this level 
of phylloquinone supplementation does not provide any significant positive benefit for bone 
health when consuming adequate amounts of vitamin D and calcium in the diet. Furthermore, 
none of the aforementioned randomized controlled trials found significant positive impacts on 
biomarkers of bone turnover in groups receiving phylloquinone supplementation.  
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More recently, research interests have shifted to examining the differences in 
effectiveness of vitamin K1 supplementation and menaquinone supplementation on bone and 
vascular health, as the contribution of menaquinones to total human vitamin K status has been 
found to be much higher than traditionally assumed.33 Schurgers et al conducted a comparison 
between absorption and efficacy of supplementation of synthetic vitamin K1 and menaquinone-7 
(MK-7), a long chain menaquinone derived from various fermented foods. A fermented soybean 
dish, natto, was used as the source of menaquinone-7 for this study. It was found that 
supplementation with MK-7 led to higher and more stable serum levels than the synthetic K1 
supplement, and demonstrated higher efficacy in hepatic and extrahepatic protein 
carboxylation.34 Additionally, MK-7 was found to be available longer for uptake by extrahepatic 
tissues than the synthetic K1; it was postulated that this was due to differences in the path of 
absorption between menaquinones and K1. After intestinal absorption, both are taken up in the 
triglyceride fractions where they are able to be cleared quickly by the liver, but higher 
menaquinones such as MK-7 then get redistributed via LDLs and are therefore available longer 
for uptake by extrahepatic tissues than K1.34 Kannelakis et al (2012) dove deeper in to examining 
the effects of phylloquinone or MK-7 consumption on bone metabolism through a 12-month 
intervention period involving enriched dairy products containing calcium, vitamin D, and either 
phylloquinone or MK-7. One hundred seventy-three women were split up in to a control group 
that received no treatment, a group consuming yogurt and milk enriched with calcium and 
vitamin D, and two groups consuming yogurt and milk enriched with calcium, vitamin D, and 
either phylloquinone or MK-7.35 All intervention groups also received biweekly nutrition and 
lifestyle counseling sessions to increase awareness of overall health issues, mainly related to 
osteoporosis. The authors found that all three of the intervention groups had significantly 
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increased intakes of calcium, vitamin D, phosphorus, and magnesium from baseline, and the 
group receiving phylloquinone supplementation also had significantly increased dietary 
phylloquinone intake. The authors also reported that both supplementation of phylloquinone and 
MK-7 induced significant increases in lumbar spine BMD compared to the control group, as 
measured through DXA, and this significance remained after controlling for serum vitamin D 
levels and dietary calcium intake. However, there was no significant difference between the 
lumbar spine BMD increases between the phylloquinone and MK-7 supplemented group.  
 
Vitamin K Regulation of RANK Expression and Osteoclast Activity 
 One of the key regulators of bone modeling and metabolism is the RANK protein, or 
receptor activator for nuclear factor κβ, in partnership with its ligand, RANKL, and its decoy 
receptor osteoprogeterin (OPG). RANK is a transmembrane protein that is ubiquitously 
expressed in skeletal muscle, thymus, liver, small intestine, adrenal gland, pancreas, prostate, 
epithelial cells of the mammary gland, and osteoclasts.36 The binding of RANKL to RANK has 
been well established as providing the signaling cascade that drives osteoclast development and 
function. In particular, RANK stimulation through RANKL binding leads to the inhibition of 
osteoclast apoptosis and influences the fusion of osteoclast precursors to form multinucleated 
cells, the differentiation of these cells into mature osteoclasts, the attachment of osteoclasts to 
bone, and the activation of osteoclasts to resorb bone.37 The decoy receptor OPG is a major 
regulator of bone resorption, as it competes with RANKL and inhibits osteoclast activation to 
promote bone formation. This prevents excessive bone resorption and is a critical point at which 
a disruption can lead to the pathogenesis of a disease state involving osteoporosis or 
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osteopetrosis; decreased OPG competition leads to increased bone resorption and increased OPG 
competition leads to increased bone formation.37 
Because of the importance of maintaining the delicate balance between bone resorption 
and formation, research has shifted to examine potential dietary influences on RANK stimulation 
and proper function. A recent study by Wu et al examined the inhibitory effect of vitamin K1 and 
K2 on RANKL-induced osteoclast differentiation and bone resorption to further examine the 
relationship between vitamin K and bone metabolism.22 MK-7 is thought to possibly have a 
direct suppressive effect on osteoclast differentiation and activity through downregulation of 
NFκβ activation. Through this study, it was demonstrated that MK-4 and MK-7 significantly 
inhibited RANKL-mediated osteoclast differentiation of bone marrow macrophages without any 
evidence of cytotoxicity; both forms of K2 were shown to inhibit osteoclast formation through 
significant suppression of specific osteoclast differentiation markers. It was also found that the 
same dose of vitamin K1 did not show significant inhibition of RANKL-induced osteoclast cell 
formation as each form of K2 did, and K1, MK-4, and MK-7 were all found to strongly inhibit 
osteoclastic bone resorption in a dose-dependent manner.22 Wu et al concluded that these results 
showed vitamin K2 in the forms of MK-4 and MK-7 have direct inhibitory effects on RANKL-
induced osteoclast differentiation, while vitamin K1 may have somewhat of a synergistic effect 
on osteoclast formation, and MK-4, MK-7, and K1 all show inhibitory effects on bone resorption 
activity after osteoclasts are formed.   
Study Objectives 
This study was designed to identify specific micronutrients that make significant contributions to 
bone mineral density in a population of physically active pre-menarcheal females. 
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Methods 
Study Design 
A cross-sectional design will be used to examine a subset of data from a larger on-going 
longitudinal study on bone growth and physical activity in young females.38 The original study 
was designed to compare activity and bone density data between gymnast and non-gymnasts. 
The data used in this analysis were collected from January 2009 to September 2012 from 52 pre-
menarcheal female gymnasts and non-gymnasts between the ages of 9-11. The original 
longitudinal study was approved by the SUNY Upstate Medical College internal review board, 
while the cross sectional analysis of a subset of the data was approved by the Syracuse 
University internal review board.   
Participant Recruitment/Demographics 
The on-going longitudinal study recruited participants from gymnastics clubs, private 
grade schools, and athletic groups in the Syracuse, NY area. Written informed consent was 
obtained from both the participants and their parents prior to participation in the study. At the 
time of enrollment, all study subjects were between 7-12 years of age (n=122, total longitudinal 
study). The subjects included in the present analysis consist of 52 pre-menarcheal females 
representing both gymnasts and non-gymnasts. The selection criteria for this analysis was limited 
to participants who self-reported as Tanner Stage I (Tanner breast I and Tanner pubic I) at the 
time of the annual DXA scan. This criterion minimizes the potentially confounding effects of 
estrogen on bone density and mineral concentration. Non-Caucasian subjects were not included 
in this analysis as the original cohort of subjects were predominantly Caucasian and the sample 
size for the current study was too small to account for racial variation. Anthropometric 
measurements and data for body composition, calcium intake, and pubertal stage were collected 
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on a semi-annual basis.38 Dietary questionnaires were completed in person during the 
measurement sessions.  
Measurements 
Dietary Analysis: Harvard's Youth/Adolescent Questionnaire (YAQ) was used to 
quantify nutrient intakes for the target population. A validity study was previously done in which 
the questionnaire was administered to 261 youths (ages 9 to 18) twice at an interval of about a 
year, and three 24-hour dietary recalls were collected during this time.39 Fifty-seven percent of 
the subjects were between the ages of 9-13, and 96% of the subjects were Caucasian, allowing 
the results to be applied to our study due to similar study populations. The validity of the 
questionnaire was tested through comparison of the average of the two YAQs and the average of 
the three 24-hour dietary recalls. After examining Pearson correlation coefficients, the authors 
concluded that the questionnaire was a valid method whose correlations against the gold standard 
24-hour recall were comparable to that of adults using similar instruments.40   
Photocopies of the questionnaire were distributed to participants at 6-month intervals 
during physical measurement sessions. Participants completed the questionnaire with aid from 
parents when necessary. Trained research assistants transferred participants’ responses to actual 
copies of the questionnaire. Research assistants also coded sections of the questionnaire that 
required participants to list any dietary supplements, cold cereals, and brands of margarine that 
they consumed in their households. Data were analyzed in the laboratory of Helaine Rockett, MS 
RD FADA (Harvard University), Channing Laboratory 3rd Floor, Brigham and Women’s 
Hospital, 181 Longwood Ave, Boston, MA 02115.  
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Bone Density Measurements: All subjects underwent annual scans using a Hologic Discovery A 
densitometer (Waltham, MA). All scans were performed by a trained technician using the 
standard protocol employed in the ongoing longitudinal study.38 Associated Hologic software 
was used to determine BMC (bone mineral content) and areal BMD (a derived volumetric 
density of calcium hydroxyapatite expressed in g/cm3). The following sites were measured:  
a. Lumbar spine: L1-L4 (AP)  
b. Total body: total and sub-head regions (necessary to measure body composition, AP) 
Scans were analyzed by a single investigator that was blind to subject status. 
 
Physical Activity: Physical activity levels were self-reported by participants every 6 months 
during a semi-annual interview session. Participants were asked to report type of activity and 
hours per week of participation to determine annual mean hours per week of participation in 
gymnastics and other organized activities for the time period leading up to and including the 
scans.  
 
Physical Maturity: Tanner breast and pubic stage were self-assessed by subjects, using standard 
line drawings of breast and pubic hair development, as has been previously reported to be valid 
for this age group.41 
 
Anthropometrics: Total stature and sitting height were measured using wall-mounted rulers and a 
right angle. Weight was measured using an electronic scale (Detecto, Webb City, MO).  
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Statistical Analysis 
The combined diet and activity data for the sub-sample of subjects included in the current 
study resulted in a large data set containing many variables with a high degree of collinearity. 
Before any analyses relevant to the objectives of this study could be completed, it was necessary 
to reduce the dimensionality of the data set. Prior analyses of some aspects of these data 
suggested correlations existed between several of the nutritional variables and bone density 
measures of interest.38,42 When evidence exists for an underlying structure to the data, factor 
analysis is the appropriate statistical method to reduce the number of variables included in the 
analysis while minimizing the loss of relevant information. The results of the factor analysis 
pointed to specific dietary variables as being able to explain the majority of the variance in the 
data set (vitamin A, beta-carotene, carotenoids, fiber, vitamin K1, and vitamin D), we decided to 
focus on examining the relationships between these variables and DXA derived bone mineral 
density for the rest of our analyses. Although other metrics were possible (e.g., calculated BMC), 
BMD appeared to be the common marker used in other dietary studies of mineral metabolism. 
Pearson correlation coefficients and simple linear regressions were used to determine 
whether changes in specific micronutrient levels led to significantly higher measures of bone 
mineral density. Multiple regression analysis and general linear ANOVA models were used to 
look for potential interactions between the intake of vitamin A, K1 and D with BMD. Physical 
activity, participant age and weight were used as covariates for these analyses. Finally, the 
relationship between the intake ratio of vitamin A: vitamin D and bone mineral density was 
separated into quartiles and an ANOVA (GLM) was used to determine if there were significant 
differences between each intake quartile in terms of bone mineral density values.  
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Part II: Thesis Manuscript 
Introduction  
 Vitamin A plays an important role in bone metabolism, as osteoblasts and osteoclasts 
both contain nuclear receptors for retinoic acid, the active form of vitamin A in the body. 
Epidemiological studies examining the relationship between vitamin A intake and measures of 
bone metabolism have produced mixed results. Some studies propose that increased vitamin A 
intake is related to decreased BMD and increased risk of fracture, while others have been unable 
to show any statistically significant relationship between vitamin A intake on bone loss or 
fracture risk. Some studies even suggest that an increase in vitamin A intake may be protective 
against bone loss.12,13 However, it has also been well-established that vitamin A toxicity, or 
hypervitaminosis A, is associated with symptoms of bone abnormalities and loss.43  
The precise mechanism through which vitamin A impacts bone metabolism has yet to be 
completely elucidated. It has been proposed that vitamin A is able to function through a genomic 
interaction to influence bone metabolism, as supported by the presence of retinoic acid receptors 
in osteoblasts and osteoclasts, as well as through findings of recent in vitro studies and studies 
using animal models.44 In recent work using bone organ culture, it was shown that vitamin A was 
able to stimulate bone resorption and osteoclast formation through retinoic acid-stimulated 
increases in mRNA production and protein expression of the osteoclastogenic cytokine, 
RANKL.45 Additionally, cell culture study results have pointed to the potential for an optimality 
curve for vitamin A intake in relation to bone health. The optimality concept is supported by 
evidence that retinoic acid functions to inhibit osteoblast differentiation at nanomolar 
concentrations, but can also stimulate osteoblast differentiation at micromolar concentrations.44  
This suggests there is an optimal concentration of retinoic acid that might balance these opposing 
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cell differentiation processes. These findings, along with the mixed results of epidemiological 
studies, prompted our interest in focusing on the potential relationships between vitamin A intake 
and bone mineral density in the analysis presented here. Our target study population consists of 
premenarcheal females. Young women at this stage of development may be sensitive to dietary 
factors, such as vitamin A, that could have long lasting negative impacts on bone mineral density 
and increases the risk of fracture later in life. Because of this, we chose to examine the relatively 
unexplored areas of the relationships between bone mineral density and the intake of vitamin A, 
beta-carotene, carotenoids, RAE, fiber, vitamin K, and vitamin D in a population of 
premenarcheal female gymnasts and non-gymnasts. The fat soluble vitamins are known to 
function as ligands for transcription factors important in regulating bone mineralization. These 
transcription factors work in pairs as homo or heterodimer structures, with one of the two dimer 
proteins being a retinoic acid receptor (RXR). Since the RXR receptor is a common protein 
anchor for several transcription factor structures, it is likely that more vitamin A must be 
ingested than vitamins D or K to form functional heterodimer units. However, what this ratio 
might be is unknown at this time. The final goal of the current analysis is to investigate whether 
bone mineral density can be used as a biomarker to estimate adequate intake ratios of preformed 
vitamin A with reference to other vitamins, specifically vitamin D and K.  
 
Data Reduction and Statistical Analysis 
 A factor analysis was used to reduce the dimensionality of the data set and the number of 
variables being examined. Two rounds of factor analysis were completed. The results of the first 
analysis allowed us to narrow down the number of factors to be determined for the second trial. 
The first factor analysis included all dietary and bone variables included in the data set (see 
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Appendix B). Six components had Eigenvalues above 1.0 and accounted for 90% of the variance 
in the data. All six factors were therefore retained for the second factor analysis. After the first 
factor analysis, total fat, animal fat, vegetable fats, carbohydrates, protein, body fat and lean 
mass, and all body composition measures except for bone mineral density and bone mineral 
concentration of the lumbar spine were removed from the analysis to reduce the high degree of 
collinearity. 
Factor loadings greater than 0.50, disregarding sign, were used to define the components 
of the second factor analysis (appendix C). Component 1 explained the majority of the variance 
of the data and was strongly correlated with vitamin B2, zinc, vitamin B1, niacin, folate, retinol 
activity equivalents (RAE), iron, vitamin B12, vitamin D, retinol, folic acid, vitamin A, beta-
carotene, and carotene. The unusual mixture of fat and water soluble vitamins suggested this 
component represented dietary supplementation. The correlation matrix confirmed that these 
nutrients, which normally would not occur together in unfortified foods, were highly correlated 
(appendix C).  Component 2 showed high correlations with tryptophan, sodium, saturated fat, 
monounsaturated fat, phosphorus, potassium, calcium, and lactose. These micronutrients are 
most likely associated with milk and nut butters. Component 3 was strongly negatively 
correlated with fiber, alpha-carotene, vitamin K, and manganese. Component 4 was correlated 
with alpha-carotene, subtotal fat mass, and subtotal lean body mass. Component 5 explained 6% 
of the variance and represented measures of bone mineral density and body composition; bone 
mineral density anchored this component. A plot was made of the first three components to see if 
dietary components and body composition variables separated graphically. After examining 
these components, we decided to focus primarily on the relationships between bone mineral 
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density (component 5) and the fat soluble micronutrients in components 1 (vitamin A, vitamin D, 
and RAE) and 3 (fiber and vitamin K).  
A series of simple linear regressions were run using data from all subjects to examine the 
relationships between BMD and the vitamins and minerals that stood out in the preliminary 
factor and principal component analyses (fiber, beta-carotene, vitamin K, vitamin A, vitamin D, 
and carotenoids). We chose variables for the rest of our analyses that were less likely to be 
highly collinear and confirmed collinearity for all multiple regressions using tolerance statistics. 
A tolerance value below 0.20 was considered highly collinear. BMD measures were log10-
transformed to obtain a normal distribution. The log10-transformed BMD values were used for all 
subsequent regression analyses. A simple linear regression was run to examine the relationship 
between bone mineral density and average weekly hours of physical activity. Finally, multiple 
linear regressions were run for a different response variable, namely the change in BMD between 
the time the participant entered the study (time 1) and the most recent bone density measurement 
(time 2). The change in BMD over time was regressed against the most recent reported intake of 
vitamins A, D, and biologically active vitamin K. Vitamins that had positive slopes in the first 
regression analysis were grouped together for subsequent regressions. The age at final BMD 
measurement, participant weight, and physical activity were used as covariates for these analyses 
and all variables were entered into the models at the same time to avoid biasing the results. 
Biologically active vitamin K1 values were determined by subtracting the intakes of 
dihydrophylloquinone from the overall phylloquinone intakes reported for each subject. The 
interaction between vitamins A, D, and the ratio of vitamin A to D intake with bone mineral 
density were further explored by dividing each vitamin distribution into quartiles using a nearest 
rank method.  
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Results 
The output from the principal component analysis is shown in Figure 3. Only components 1, 
2, and 3 are shown as these explain the majority of the variance in the data set. Four major 
groupings of variables resulted (A, B, D, E) and one smaller grouping (C) that could have been 
associated with the two adjacent groupings. 
 
Figure 3: Graphical representation of component 3 vs component 1 vs component 2 from 
principal component analysis with labeled groupings. A. Grouping of bone measures, body 
composition measures, and lactose and calcium. B. Grouping of B vitamins, vitamins A, C, and 
D, and minerals, which are potentially related to supplementation. C. Grouping of beta-carotene 
and carotene, which falls between the potential supplementation grouping and a grouping of 
nutrients related to plant-foods. D. Grouping of vitamin K, alpha-carotene, manganese, and fiber, 
which are potentially related to plant-based intake. E. Grouping of nutrients potentially 
associated with animal products and/or nut butters, including the omega fatty acids, tryptophan, 
sodium, saturated fat, phosphorus, monounsaturated fat, potassium, and magnesium.  
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The first grouping (A) consisted of bone measures, body composition measures, lactose, and 
calcium; this was not surprising as lactose and calcium are generally regarded as having strong 
relationships to bone, as lactose enhances the absorption of calcium by enterocytes. Grouping B 
consisted of all the vitamins in our data set, both water soluble and fat soluble, as well as many 
minerals. High concentrations of both water soluble and fat soluble vitamins are unlikely to 
occur together in unfortified foods, leading us to conclude that this grouping was related to 
supplementation. Grouping C was a sub-group that consisted of just beta-carotene and carotene, 
and fell very close to both Grouping B and Grouping D. Grouping D consisted of vitamin K, 
alpha-carotene, manganese, and fiber, all of which are nutrients that may be associated with 
plant-based foods. Therefore, we believe that Grouping C may be associated with both 
supplementation as well as intake of plant-based foods. Finally, Grouping E consisted of 
nutrients that are commonly found in dairy products, meat, and nut butters, such as 
monounsaturated fat, saturated fat, sodium, tryptophan, phosphorus, magnesium, omega fatty 
acids, and potassium. 
After carefully examining these groupings individually, we chose to focus on the fat-soluble 
micronutrients (vitamin A, vitamin D, carotene, and beta-carotene) as well as fiber and vitamin 
K, in relation to bone mineral density. Bone mineral density was chosen as the biomarker for this 
analyses as an extensive literature review suggested that it was the most frequently used measure 
to examine relationships between dietary variables and bone. 
Although some studies have shown that physical activity can account for up to forty 
percent of bone density,46 the correlation was not statistically significant for this data set 
(r=0.157; β=0.157; p=0.138, appendix D). Weak, but statistically significant inverse correlations 
were found to exist between dietary intakes of beta-carotene and bone mineral density (r= -
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0.337; β= -0.337; p=0.008), carotene and bone mineral density (r= -0.344; β= -0.344; p=0.007), 
vitamin A and bone mineral density (r= -0.297; β= -0.297; p=0.018), and fiber (r= -0.270; β= -
0.270; p=0.029). Weak, but statistically significant correlations were also found between bone 
mineral density and beta-carotene intake (r2=0.113; p=0.017), bone mineral density and carotene 
intake (r2=0.118; p=0.014), and bone mineral density and vitamin A intake (r2=0.088; p=0.036). 
There was no statistically significant relationship between the dietary intake of vitamin K1 
(phylloquinone) and bone mineral density of the lumbar spine (r= -0.083; β= -0.083; p=0.284). 
The correlation analyses were not adjusted for activity level, participant age, or weight, 
so additional multiple regression analyses were used to further explore significant correlations. 
Bone mineral density increased (adjusted R2=0.270, p=0.006, Appendix E) with the positive 
interaction between change in body weight (β= 0.455; p=0.022) and the intake of biologically 
active vitamin K (K1 minus dihydrophylloquinone β= 0.282; p=0.048, Fig. 4). Although not 
significant itself, vitamin D had to be present in the statistical model in order for the biologically 
active K1 and BMD relationship to be significant (Appendix E). The change in BMD over the 
period of study participation was also significantly correlated with the last reported vitamin A 
intake (β= 0.232; p=0.031, Fig 5) and the change in participant weight (β= 0.815; p=0.0001, Fig. 
6) when adjusted for age, and physical activity (adjusted R2=0.553, p=0.0001, Appendix E). As 
weight increased, the contribution of the fat soluble vitamins A and K to increased bone density 
became more important, while the contribution of vitamin D to the change in BMD remained the 
same (Fig. 7 and Fig. 8).  
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Figure 4: Bone mineral density vs intake of biologically active vitamin K. Partial regression plot 
from the multiple regression analysis of log normalized bone mineral density as a function of 
biologically active vitamin K, vitamin D, participant age, weight, and physical activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5: Change in BMD from beginning of study participation to most recent DXA scan vs 
most recently reported vitamin A intake, when adjusted for age and physical activity. Partial 
regression plot from the multiple regression analysis of the change in bone mineral density over 
time as a function of biologically active vitamin A, participant age, weight, and physical activity. 
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Figure 6: Partial regression plot of the change in BMD from beginning of study participation to 
most recent DXA scan vs change in weight from first measurement to most recent measurement, 
when adjusted for age and physical activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Partial regression plot of log normalized bone mineral density as a function of the most 
recently reported intake of vitamin D, with respect to change in weight.  
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Figure 8: Partial regression plot of the change in BMD from beginning of study participation to 
most recent DXA scan as a function of most recently reported intake of vitamin D, participant 
age, weight, and physical activity. 
 
To further explore the relationship between fat soluble vitamin intake and BMD, the individual 
participant intakes of vitamin A and vitamin D were assigned percentiles using a nearest rank 
method. The percentiles were then used to divide intake distribution into quartiles. Figure 9 
depicts a boxplot of vitamin A levels in each quartile of vitamin A intake. The lowest BMD was 
found to coincide with the highest quartile of vitamin A intake, which contains intake values that 
are all above the UL for vitamin A intake for this age group (Figure 10; Appendix F). Similarly, 
Figure 11 depicts a boxplot of vitamin D levels separated by quartile of vitamin D intake; the 
lowest BMD was again associated with the highest quartile of vitamin D intake. All intakes in 
this quartile were above the DRI for vitamin D intake. 
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Figure 9: Vitamin A intake levels as separated by quartile of intake for all subjects. All quartiles 
exceeded the DRI of 2000 IU for the study population demographic. The lowest BMD were 
associated with the highest quartile of vitamin A intake.  
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Figure 10: Bone mineral density (g cm−3) as a function of vitamin A (IU) intake in a population 
of pre-adolescent girls. Vitamin A intake was divided into quartiles for this analysis. The 
reported means have been adjusted for age, body mass index, and physical activity levels; error 
bars are 95% confidence intervals (Appendix F). Although not statistically significant, bone 
mineral density was lowest at the highest level of vitamin A intake. Bone density was highest at 
intermediate levels of vitamin A intake. 
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Figure 11: Vitamin D intake levels as separated by quartile of intake for all subjects. The highest 
quartile of vitamin D intake was associated with the lowest BMD (4st quartile of vitamin D, 
mean ± stdev = 0.59±0.013 g/cm3). The highest BMD was associated with the intermediate 
levels of vitamin D in the 2nd and 3rd quartiles (2nd quartile, mean ± stdev = 0.64 ±0.029 g/cm3 
and 3rd quartile, mean ± stdev = 0.65 ±0.017 g/cm3. The 3rd quartile encompassed the current 
daily recommended intake of vitamin D for the study population demographic.  
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Figure 12: Bone mineral density (g cm−3) as a function of the difference between vitamin A (IU) 
to vitamin D (IU) intake in a population of pre-adolescent girls. The difference between vitamin 
A and vitamin D intake was divided into quartiles for this analysis. The reported means have 
been adjusted for age, body mass index, and physical activity levels (Appendix F). Although not 
statistically significant, bone mineral density was lowest when vitamin A was either very high 
(4th quartile, mean ± stdev = 17,317.34 ±4358.86 IU) or very low (1st quartile, mean ± stdev = 
5243.01 ±1230.68 IU) with respect to vitamin D intake. Intermediate levels of vitamin A:D ratio 
encompass the highest bone densities.  
 
 
Discussion 
 One of the most interesting findings of our study was the statistically significant inverse 
association between intake of dietary fiber and bone mineral density of the lumbar spine. Fiber 
can affect dietary energy availability and the digestibility of complex foods as it can interact with 
protein and fat to decrease their digestibility. Dietary fiber also increases the bulk of intestinal 
contents, speeding up the transit time through the gut. This leaves less time for minerals such as 
calcium and magnesium to be absorbed by the body. In a study examining factors associated 
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with calcium absorption efficiency in pre- and perimenopausal women, Wolf et al found that 
fractional calcium absorption was inversely associated with dietary fiber intake.47 Additionally, 
they observed that women in the lowest tertile of dietary fat to fiber ratio had a 19% lower 
fractional calcium absorption than women in the highest tertile. These observations may help to 
explain the relationship that we found between higher fiber intake and lower bone mineral 
density, as it implies that though calcium may be ingested in adequate amounts, it may not be 
efficiently absorbed if dietary fiber intake is too high.  
Further evidence to support the hypothesis that high fiber intake may contribute to lower 
BMD comes from a recent study examining dietary intake and associations of specific nutrients 
with lumbar spine bone mineral density in female athletes with oligomennorhea compared to 
eumenorrhic athletes and nonathletes.48 The authors observed that though oligomennorhic 
athletes displayed higher intakes of dietary calcium and vitamin D than the other two groups, 
these athletes also had higher intakes of dietary fiber, phytates, and oxalates, all of which were 
associated with lower BMD z scores. These effects remained even after controlling for body 
weight, menstrual status, calcium intake, and serum vitamin D levels. The negative effects on 
BMD were postulated to be associated with the effects of fiber on mineral absorption as 
previously described, as well as potentially through the effects of phytic acid. Intake of phytic 
acid was positively associated with fiber intake in this study. Phytates bind minerals, proteins, 
and starches, which can affect the solubility, functionality, digestion, and absorption of important 
bone-related minerals such as calcium and magnesium.49 Therefore, it is possible that a 
simultaneous increased intake of fiber and phytic acid exerts negative impacts on bone health 
through the binding and subsequent decreased absorption of minerals important to bone health; 
this effect would potentially explain the relationship reported in the current study. 
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We also found a significant inverse association between vitamin A intake and bone 
mineral density of the lumbar spine. Retinoic acid plays a critical role in the regulation of gene 
expression during development, and chronic, high intakes of vitamin A are known to induce 
symptoms of toxicity including decreased bone mineral density. Some observational studies 
have found that intakes of retinol at levels slightly over the current RDA and lower than the UL 
were associated with poor bone mineral density and increased risk of hip fracture.43 Promislow 
et al found that both high and low intakes of retinol were associated with low BMD in an elderly 
population, bringing up the possibility of an optimality curve for retinol intake.50 Though this 
population differs greatly in age and stage of life from the participants in our study, these results 
are in agreement with our findings of a statistically significant association between both high 
and low intakes of intakesvitamin A and decreased bone mineral density of the lumbar spine.  
Some of the negative consequences of excess vitamin A consumption on the body may be 
explained through a potential genomic effect. Excess levels of retinoic acid in the body have 
been postulated to increase binding of RA to retinoid receptor proteins, thus increasing the 
stimulation of retinoid-responsive genes.51 This appears to be related to the postulated saturation 
of LRAT expression and activity in conditions of high vitamin A intake, particularly with 
preformed vitamin A. LRAT, or lecithin-retinol acyltransferase, is responsible for esterifying 
retinol in the liver that is bound to cellular retinol binding protein I (CRBP-I) in order to be able 
to store it. If LRAT becomes saturated, circulating levels of retinol increase; this can be 
problematic, as it can lead to inappropriate gene expression, the induction of apoptosis for some 
cells, and aberrant cell differentiation.51 Additionally, retinoic acid stimulates the formation of 
osteoclasts and inhibits the activity of osteoblasts, so increased levels of retinoic acid in the 
bloodstream could potentially have a negative impact on bone density through these 
36 
 
 
 
mechanisms.52 Therefore, it appears that the LRAT esterification step may be of critical 
importance in regulating vitamin A levels, and excess intake of preformed vitamin A through 
supplementation could be highly detrimental to the body and bone health if vitamin A levels 
become too great for the enzyme to handle.  
Dietary intakes of preformed vitamin A, as would be found in supplementation, or other 
carotenoids may also affect the intestinal absorption or conversion of beta-carotene to vitamin A, 
as vitamin A status impacts the conversion process. If there is too much retinoic acid present in 
the blood, the body employs a negative feedback loop that shuts down the conversion of beta-
carotene to retinoic acid. The reverse is seen in those with poor vitamin A nutritional status, as 
vitamin A deficiency has recently been shown to induce the expression of BCMO1, the key 
enzyme that converts beta-carotene to vitamin A in the intestinal cells.53 The same study also 
reported BCMO1 expression was shown to be suppressed in conditions of excess vitamin A or 
its active metabolites, suggesting the role of a feedback loop influenced by vitamin A status. By 
suppressing the conversion of beta-carotene to active vitamin A, this gives the body a 
mechanism to prevent the aforementioned detrimental effects of excess retinoic acid in the blood 
stream. However, this may be another situation where preformed vitamin A ingestion can be 
harmful; preformed vitamin A that is ingested would be able to bypass this conversion process 
entirely and would therefore be much more likely to lead to excess serum retinoic acid, 
especially if the LRAT enzyme becomes saturated. 
Statistically significant inverse associations were found between carotenoid intake and 
bone mineral density as well as beta-carotene intake and bone mineral density. This is 
contradictory to the findings of multiple epidemiological studies showing an association 
between increased intake of foods containing higher amounts of carotenoids with higher BMD 
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levels. Yang et al (2008) also found that women with osteoporosis had lower serum 
concentrations of lycopene and cryptoxanthin than women with higher BMD.54 The 
Framingham Osteoporosis study found similar results, as they reported that lycopene intake 
appeared to be protective against lumbar spine BMD loss in women over a period of four 
years.55 Increased intakes of total carotenoids, beta-carotene, lycopene, lutein, and zeaxanthin 
were also reported to be protective against trochanter bone loss in men over the same period. 
Specifically, participants in the highest tertile of total carotenoid intake were associated with a 
46% lowered risk of hip fracture, and those with higher lycopene intake were associated with a 
34% reduction in hip fracture risk and risk of non-vertebral fracture. Thus, it appears quite 
possible that dietary forms of vitamin A are not equal when it comes to their influence on bone 
health, but extensive research is still needed in this area to elucidate the mechanisms that bring 
about these differences in effect.  
 Fiber may again play a role in helping to explain our findings that beta-carotene and 
carotenoids were significantly associated with decreased bone mineral density. Plant sterols and 
other water-soluble fibers like pectin have been shown to decrease the absorption of beta-
carotene, lycopene, lutein, and tocopherols.56 Riedl et al also found that in a study of German 
women, water soluble fibers like pectin, guar, and alginates reduced the bioavailability of beta-
carotene by about 33 to 34%.57 These findings are of relevance to our study as they may in part 
explain why increased intakes of total carotenoids and beta-carotene were associated with 
decreased bone mineral density when epidemiological studies have generally shown positive 
associations between carotenoid and beta-carotene intake and bone density; if our subjects were 
taking in a high level of fiber, this may have negatively impacted their absorption of beta-
carotene and carotenoids. This would potentially decrease or cancel out the protective effects on 
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bone that have been associated with these nutrients, which would lead to lower levels of bone 
mineral density.  
Though we expected to see a significant relationship between bone mineral density and 
vitamin K2 intake, the YAQ data only provide direct dietary intake values for vitamin K1. We 
could not, therefore, conclusively report on the intake of vitamin K2 without estimates of dietary 
intake of specific foods known to contain vitamin K2 (cheeses, dairy products, fermented foods). 
Initailly, no statistically significant correlation was found between dietary intake of vitamin K1 
and bone mineral density of the lumbar spine in the total sample, which is consistent with 
previous observational studies examining dietary intake of phylloquinone and bone 
mineralization markers in a similar population of young girls.26  
 Although we did not find a statistically significant direct relationship between total 
vitamin K1 and bone mineral density, but we did see an intriguing interaction between increased 
K1 intake, increased body mass, and increased BMD over the course of the course of the study 
when these variable were modeled together. There are a few aspects of this relationship that 
warrant further investigation. First, biologically active vitamin K1 was defined here as the intake 
of dihydrophylloquinone subtracted from the total intake of vitamin K1. We used the resulting 
value for additional analysis beyond simple regression, as it has been suggested that 
dihydrophylloquinone, a synthetic form of phylloquinone produced during vegetable oil 
hydrogenation, does not have the same capacity for the gamma-carboxylation of osteocalcin as 
phylloquinone.58 Booth et al reported that after short-term dietary phylloquinone restriction and 
subsequent repletion with either phylloquinone or dihydrophylloquinone, dihydrophylloquinone 
was not found to have any measurable biological effects on markers of bone turnover. 
Phylloquinone repletion, however, was able to restore baseline values in healthy adult males.59 
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Additionally, previous research has suggested that dihydrophylloquinone can contribute to as 
much as 30% of vitamin K intake in children, so we wanted to ensure that we were examining 
only the potential interactions of biologically active phylloquinone intake with bone metabolism 
by excluding the values for dihydrophylloquinone.60  
To the best of our knowledge, this is a novel finding for this age group. The statistically 
significant relationship between biologically active vitamin K1 and BMD is only present when 
vitamin D is accounted for in the model. This implies that vitamin K1 and vitamin D may 
participate in an interaction that impacts bone metabolism. This is a relationship that has not 
been extensively explored in previous research; however, a recently proposed mechanism seems 
to be in line with what we have found. Masterjohn proposed that excess intake of vitamin D 
could induce a deficiency of vitamin K through its role in the upregulation of the expression of 
vitamin K-dependent proteins.61 If the level of these proteins were to exceed the pool of vitamin 
K available in the body for the necessary gamma-carboxylation process, it could result in a 
relative deficiency of vitamin K and subsequent undercarboxylation of many vitamin K-
dependent proteins. One of the major vitamin K-dependent proteins that would potentially be 
impacted by such an event is osteocalcin, the non-collagenous bone protein in osteoblasts that 
has a high affinity for mineralized bone matrix and is thought to thus be involved in bone 
mineralization.62 If the glutamic acid residues on this protein are not able to undergo gamma-
carboxylation by vitamin K, this could potentially lead to a negative impact on bone 
mineralization through a decreased affinity for bone matrix, giving a possible mechanism 
through which a low vitamin K to vitamin D ratio could negatively impact bone metabolism. 
Osteocalcin’s exact role in bone metabolism has not yet been elucidated, limiting the further 
development of this mechanism until further research has been done to determine this protein’s 
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precise function in bone metabolism. However, a different interaction between vitamin D and 
vitamin K1 that could negatively impact bone density is supported by recent findings. In a mouse 
model, vitamin D was found to significantly reduce vitamin K uptake in a dose dependent 
manner by up to 58%.63 The authors of this paper were unable to propose a mechanism for this 
result, but did postulate that vitamin K and vitamin D may share common uptake pathways, 
suggesting that vitamin D is able to outcompete vitamin K. If this is the case, this could 
potentially link to the previously proposed mechanism for an interaction between vitamin K and 
D; increased intake of vitamin D could lead to a relative deficiency of vitamin K through 
upregulation of vitamin K-dependent proteins, and could also be reducing the available vitamin 
K through outcompeting it for uptake. This relationship clearly warrants further investigation, as 
our results point to the ratio of intake of vitamin K1 to vitamin D as having a sizable impact on 
bone density when physical activity is factored in.  
The role of physical activity in any potential vitamin K and vitamin D interaction also 
warrants further examination due to the major role exercise plays in the bone remodeling 
process. We used physical activity as a covariate when analyzing the relationship between BMD 
and vitamins K1 and D as we were interested in examining the impact of the dietary variables 
without interference from the mechanical influence on bone building. It would, however, be 
interesting to test whether or not increased physical activity could offset some of the potential 
negative effects of a low ratio of vitamin K1 intake to vitamin D intake, or if the dietary 
interaction plays too great a role in the bone metabolism process for this to occur. Once again, 
this is a topic for further investigation; this information could be of great importance when 
determining physical activity and dietary guidelines for prepubertal females.  
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The final relationship that we examined was that of bone mineral density to the ratio of 
vitamin A to vitamin D intake. We observed curvilinear patterns of BMD across quartiles of 
vitamin A and across quartiles of the ratio of vitamin A:D intake. These patterns suggest there 
may be an optimal intake of these micronutrients with respect to each other. Again, to the best of 
our knowledge this is a novel finding for this age group and is an area that has not been 
extensively explored in research thus far. We believe that this observed relationship may in part 
be resulting from two potential interactions between vitamin D and vitamin A, one of which is 
genomic. First, this relationship may stem from a role in the previously proposed mechanism of 
vitamin D’s interaction with vitamin K1 impacting bone mineral density. In the same paper as 
the aforementioned mechanism, Masterjohn also proposed that vitamin A could work to protect 
against vitamin D’s potential negative impact on vitamin K1 through its ability to downregulate 
matrix Gla protein.61 This could effectively reduce the demand for carboxylation of these Gla 
residues on vitamin K-dependent proteins, and therefore exert a vitamin K-sparing effect to 
counteract the depletion that increased levels of vitamin D are proposed to induce in this 
hypothetical mechanism. If this is found to be true, this may also imply that symptoms of vitamin 
D toxicity are actually a function of the balance between vitamins A, D, and K, and not just the 
level of vitamin D alone. Therefore, there is the potential for an optimality curve for the ratio 
between vitamin A intake to vitamin D intake in relation to bone health; instead of each of these 
individual vitamins displaying linear relationships with bone mineral density, our data suggests 
that the ratio of intake of these two vitamins needs to be considered. In particular, our results 
appear to show that the lowest values for bone mineral density were associated with the highest 
intakes of vitamin D as well as the highest intakes of vitamin A, but the second highest ratio of 
vitamin A to vitamin D intake. In other words, the lowest bone density values were associated 
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with the biggest difference between vitamin A and vitamin D intake levels. In contrast, the 
highest values of bone mineral density in our sample were associated with a much smaller 
difference between vitamin A and vitamin D intakes. This leads us to believe that very large 
differences in the intakes of vitamin A and vitamin D may be detrimental to bone health, while 
smaller differences in the intake levels of the two are potentially of benefit to bone health.  
Similar findings to what we have shown here have been recently reported in two 
observational studies. A recent analysis of the 2008-2011 Korea National Health and Nutrition 
Examination Survey found that total hip and femoral neck BMD in men and lumbar spine BMD 
in women were positively correlated with dietary vitamin A intake in participants who had serum 
vitamin D levels in the uppermost tertile.64 The authors also reported that men in the lowest 
tertile of vitamin D intake had lower BMD in the highest A tertile and the lowest A tertile than 
the middle tertile of vitamin A intake; this corroborates with our results, as we saw the lowest 
BMD in participants with the biggest differences in vitamin A intake to vitamin D intake. Once 
again, these results point to the possibility of an optimality curve for vitamin A to vitamin D 
intake when dealing with bone health, as it appears that the largest differences in vitamin A to 
vitamin D intake are related to negative bone outcomes at the lowest and highest intakes of 
vitamin A.  Mata-Granados et al also reported similar findings in a recent cross-sectional study 
examining the association between vitamin D deficiency or insufficiency combined with excess 
vitamin A intake as a risk factor for osteoporosis in postmenopausal women.65 The authors found 
that BMD measurements revealed the risk of osteoporosis to be eight times higher in women 
with the highest retinol levels as compared to those with the lowest retinol levels. They also 
found that in women with deficient levels of vitamin D, the risk for osteoporosis increased 
substantially in those with the highest blood levels of retinol compared to those with the lowest 
43 
 
 
 
levels of retinol. Again, this points towards the largest differences in vitamin A to vitamin D 
intake increasing the potential for negative effects on bone health. The researchers similarly 
concluded that “an adequate bone mineral density may depend on an optimal ratio of retinol to 
25(OH)D levels as a consequence of a suitable ratio of vitamin A to vitamin D intake.”65 They 
proposed a genomic mechanism to explain this relationship: increased tissue levels of retinoic 
acid allow for greater binding to nuclear retinoic X receptor (RXR) and retinoic acid receptor 
(RAR), effectively limiting the availability of RXRs to bind the nuclear vitamin D receptor 
(VDR) and activate promotors of vitamin D responsive genes. Thus, the authors proposed that 
increased serum retinol levels with a vitamin D deficiency or insufficiency could be detrimental 
for bone and mineral metabolism by decreasing vitamin D’s ability to participate in its genomic 
activities.  
We believe that our results are in line with what was found in these studies, and would 
like to propose a further expansion of this potential mechanism. VDR is known to be involved in 
the upregulation of expression of vitamin K-dependent proteins, such as osteocalcin. 
Specifically, vitamin D3 is known to be the principal enhancer of osteocalcin expression after the 
initiation of basal transcription, and is reported to be able to increase osteocalcin gene 
transcription by three to five-fold.66 In mature, non-proliferating osteoblasts, vitamin D binds to 
the VDR to induce a conformational change and activates its translocation to the nucleus where 
it promotes an association with RXR. Then, the VDR/RXR complex is able to bind to the VDRE 
to induce transcription. Additionally, it has been reported that vitamin D is able to regulate 
osteocalcin gene expression at the post-translational level through stabilization of the osteocalcin 
mRNA.67 If excess RA in the body is leading to increased RXR homodimers and RXR-RAR 
heterodimers, this would effectively decrease the number of RXR-VDR heterodimers and 
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decrease VDR’s gene expression activity. In this case, it is quite possible that osteocalcin 
expression would be negatively impacted, thus leading to a decrease in its ability to participate in 
bone mineralization and a possibility for negative effects on bone density. This mechanism has 
not yet been fully explored in research, and clearly warrants further investigation. If this 
mechanism is able to be confirmed, this points towards a need for greater scrutiny of preformed 
vitamin A supplementation in multivitamins as well as the amounts found in fortified foods, 
particularly in developing youth; even though our participants were not ingesting levels of 
preformed vitamin A at a level of toxicity, the negative relationship we observed with bone 
density suggests the great difference in vitamin A and vitamin D intake may be associated with 
altered bone metabolism anyway. This is of great concern, as bone mineral density status at this 
developmental stage of life is known to impact fracture risk later in life, and therefore demands 
immediate further investigation in order to be able to prevent future widespread bone damage. 
Conclusion  
 To the best of our knowledge, this is the first study to examine the relationship between 
the ratio of vitamin A: vitamin D intake in a premenarcheal female population. From the 
relationships observed here, these study results support the potential for our proposed genomic 
interaction between retinoic acid and vitamin D that may negatively impact markers of bone 
health including bone density. For premenarcheal females, this potential relationship could be of 
great concern, as this is a period of development in which accruing bone mineral density is 
highly important to future bone health. Therefore, our findings support the need for further 
investigation to confirm the exact mechanism behind the observed interaction that appears   
occur when there is a great difference in vitamin A intake and vitamin D intake, even when 
vitamin D intake is sufficient according to the current RDAs for this age group. Additionally, our 
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results also support a need for greater scrutiny of dietary supplements and foods fortified with 
preformed vitamin A, as in our population, ingestion of these types of substances appeared to be 
contributing to total vitamin A and RAE intakes well above the RDAs but below a level of 
toxicity. 
 This study also identified a statistically significant relationship between the intakes of 
vitamin K1, vitamin D, and BMD, which we further believe is a novel finding for this age group 
and gender. Once again, this is a relationship that is currently lacking a well-developed 
mechanism, but our results support the need for future research efforts to look at the interaction 
between these fat-soluble vitamins more in depth as we have shown that it is possible that 
increasing the ratio of intake of vitamin K1: vitamin D may positively impact bone density in 
this population. 
 Our study was not without limitations; we employed a cross-sectional design which does 
not allow us to determine causal relationships and we had a small sample size in a group that was 
homogenous in terms of socioeconomic status and geographic location. We also observed 
extremely high reported intakes of vitamin A that may not be consistent with average intakes for 
this age group across the country. These factors may limit us from being able to extend our 
observations to individuals of similar age and activity level outside of our sample population. 
Additionally, we did not have access to biomarkers for nutrient intake, and instead just examined 
the results of a food frequency questionnaire. Though this dietary assessment tool did allow us to 
get an overall general picture of dietary intakes for our subjects, it relies on accuracy of self-
reporting and may affected by seasonality and recent changes in dietary pattern depending on 
when the questionnaire is completed. 
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Appendix B 
Variables Included in Initial Principal Component Analysis  
 
Dietary: 
Vitamin K, Vitamin A, Retinol, Carotene, Alpha-carotene, Beta-carotene, Age, Weight, BMI, 
Calories, Protein, Animal Fat, Vegetable Fat, Total Fat, Carbohydrates, Fiber, Calcium, Iron, 
Magnesium, Phosphorus, Potassium, Zinc, Vitamin C, Vitamin D, Saturated Fat, 
Monounsaturated Fat, Sodium, Vitamin B1, Vitamin B2, Niacin, Vitamin B6, Folate, Vitamin 
B12, Lactose, Tryptophan, Manganese, Omega Fatty Acids, Folic Acid 
 
Bone:  
Postero-Anterior Bone Mineral Concentration of L3 Lumbar Spine, Postero-Anterior Bone 
Mineral Density of L3 Lumbar Spine, Postero-Anterior Width of L3 Lumbar Spine, Postero-
Anterior Area of L3 Lumbar Spine 
 
 
 
 
 
 
 
 
 
59 
 
 
 
Appendix C  
PCA Analysis  
a) Correlation matrix including all variables 
 
 
 
 
 
 
 
 
 
 
aofib vitak vita RAE retinol carot acar bcar calc iron magn ph k zn vitc vitd
aofib 1.000 .457 .480 .240 .180 .537 .527 .524 .244 .339 .780 .479 .630 .306 .288 .181
vitak .457 1.000 .572 .261 .123 .677 .511 .687 -.100 .255 .246 .037 .153 .254 .162 .105
vita .480 .572 1.000 .863 .745 .953 .721 .962 .207 .770 .391 .253 .293 .794 .552 .717
RAE .240 .261 .863 1.000 .959 .681 .320 .711 .284 .925 .328 .279 .234 .952 .636 .908
retinol .180 .123 .745 .959 1.000 .512 .171 .543 .450 .852 .392 .421 .340 .904 .551 .927
carot .537 .677 .953 .681 .512 1.000 .860 .998 .067 .604 .326 .138 .225 .610 .458 .506
acar .527 .511 .721 .320 .171 .860 1.000 .826 .092 .210 .281 .130 .242 .221 .186 .198
bcar .524 .687 .962 .711 .543 .998 .826 1.000 .062 .639 .323 .136 .217 .647 .477 .533
calc .244 -.100 .207 .284 .450 .067 .092 .062 1.000 .137 .716 .928 .840 .297 .029 .562
iron .339 .255 .770 .925 .852 .604 .210 .639 .137 1.000 .358 .219 .192 .958 .678 .815
magn .780 .246 .391 .328 .392 .326 .281 .323 .716 .358 1.000 .896 .937 .429 .247 .451
ph .479 .037 .253 .279 .421 .138 .130 .136 .928 .219 .896 1.000 .949 .360 .063 .511
k .630 .153 .293 .234 .340 .225 .242 .217 .840 .192 .937 .949 1.000 .320 .186 .430
zn .306 .254 .794 .952 .904 .610 .221 .647 .297 .958 .429 .360 .320 1.000 .678 .896
vitc .288 .162 .552 .636 .551 .458 .186 .477 .029 .678 .247 .063 .186 .678 1.000 .519
vitd .181 .105 .717 .908 .927 .506 .198 .533 .562 .815 .451 .511 .430 .896 .519 1.000
satfat .343 .069 .037 .045 .186 -.040 -.002 -.042 .728 .022 .652 .772 .742 .123 -.119 .263
monfat .408 .119 .019 .039 .165 -.052 -.057 -.047 .603 .089 .712 .758 .729 .179 -.047 .202
sodium .497 .118 .021 .010 .138 -.033 -.024 -.032 .627 .057 .764 .790 .772 .131 -.039 .152
b1 .372 .221 .767 .935 .889 .582 .199 .616 .274 .982 .446 .341 .307 .974 .668 .871
b2 .356 .149 .712 .882 .921 .499 .198 .526 .639 .836 .630 .651 .594 .909 .563 .953
niacin .445 .301 .742 .875 .821 .580 .185 .617 .194 .957 .494 .345 .338 .952 .666 .778
b6 .403 .291 .771 .901 .845 .607 .224 .641 .231 .957 .470 .337 .348 .958 .728 .822
fol98 .428 .290 .771 .892 .829 .610 .231 .643 .175 .974 .431 .272 .275 .937 .711 .789
b12 .264 .170 .703 .885 .927 .485 .143 .518 .412 .845 .477 .472 .420 .886 .545 .870
lact .136 -.131 .137 .203 .374 .014 .077 .006 .970 .026 .622 .863 .790 .197 -.033 .521
trypto .560 .122 .041 -.013 .111 .003 .051 -.001 .695 .034 .849 .876 .868 .122 -.124 .186
mn .879 .281 .264 .130 .096 .290 .260 .283 .153 .325 .749 .423 .542 .250 .318 .062
omega .414 .309 -.060 -.252 -.265 .038 .101 .031 .044 -.173 .409 .262 .343 -.171 -.107 -.248
folic .245 .213 .734 .911 .849 .553 .147 .591 .102 .968 .261 .150 .129 .935 .701 .800
post_BMAD -.179 .041 -.187 -.130 -.054 -.229 -.267 -.220 .030 -.131 -.041 -.009 .008 -.139 -.042 -.097
post_ BMD -.254 -.075 -.279 -.173 -.064 -.325 -.330 -.318 .115 -.201 -.070 .046 .028 -.216 -.100 -.132
post_BMC -.302 -.031 -.193 -.121 -.050 -.215 -.207 -.210 .115 -.160 -.105 .039 -.016 -.154 -.148 -.067
SUBTOT_FAT -.239 -.054 .014 .037 .077 -.011 .036 -.015 .213 -.071 -.019 .144 .153 .037 .078 .093
SUBTOT_LEAN -.202 -.125 -.082 -.005 .056 -.116 -.068 -.117 .175 -.063 -.018 .112 .069 -.025 -.054 .032
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satfat monfat sodium b1 b2 niacin b6 fol98 b12 lact trypto mn omega folic
post_BMA
D post_BMC
post_ 
BMD
SUBTOT_
FAT
SUBTOT_
LEAN
aofib .343 .408 .497 .372 .356 .445 .403 .428 .264 .136 .560 .879 .414 .245 -.179 -.302 -.254 -.239 -.202
vitak .069 .119 .118 .221 .149 .301 .291 .290 .170 -.131 .122 .281 .309 .213 .041 -.031 -.075 -.054 -.125
vita .037 .019 .021 .767 .712 .742 .771 .771 .703 .137 .041 .264 -.060 .734 -.187 -.193 -.279 .014 -.082
RAE .045 .039 .010 .935 .882 .875 .901 .892 .885 .203 -.013 .130 -.252 .911 -.130 -.121 -.173 .037 -.005
retinol .186 .165 .138 .889 .921 .821 .845 .829 .927 .374 .111 .096 -.265 .849 -.054 -.050 -.064 .077 .056
carot -.040 -.052 -.033 .582 .499 .580 .607 .610 .485 .014 .003 .290 .038 .553 -.229 -.215 -.325 -.011 -.116
acar -.002 -.057 -.024 .199 .198 .185 .224 .231 .143 .077 .051 .260 .101 .147 -.267 -.207 -.330 .036 -.068
bcar -.042 -.047 -.032 .616 .526 .617 .641 .643 .518 .006 -.001 .283 .031 .591 -.220 -.210 -.318 -.015 -.117
calc .728 .603 .627 .274 .639 .194 .231 .175 .412 .970 .695 .153 .044 .102 .030 .115 .115 .213 .175
iron .022 .089 .057 .982 .836 .957 .957 .974 .845 .026 .034 .325 -.173 .968 -.131 -.160 -.201 -.071 -.063
magn .652 .712 .764 .446 .630 .494 .470 .431 .477 .622 .849 .749 .409 .261 -.041 -.105 -.070 -.019 -.018
ph .772 .758 .790 .341 .651 .345 .337 .272 .472 .863 .876 .423 .262 .150 -.009 .039 .046 .144 .112
k .742 .729 .772 .307 .594 .338 .348 .275 .420 .790 .868 .542 .343 .129 .008 -.016 .028 .153 .069
zn .123 .179 .131 .974 .909 .952 .958 .937 .886 .197 .122 .250 -.171 .935 -.139 -.154 -.216 .037 -.025
vitc -.119 -.047 -.039 .668 .563 .666 .728 .711 .545 -.033 -.124 .318 -.107 .701 -.042 -.148 -.100 .078 -.054
vitd .263 .202 .152 .871 .953 .778 .822 .789 .870 .521 .186 .062 -.248 .800 -.097 -.067 -.132 .093 .032
satfat 1.000 .895 .792 .116 .393 .111 .104 .071 .228 .663 .784 .233 .262 -.021 -.007 -.013 .036 .098 -.022
monfat .895 1.000 .886 .158 .368 .237 .172 .128 .262 .512 .834 .407 .352 .014 -.056 -.053 -.017 .052 -.023
sodium .792 .886 1.000 .144 .345 .232 .160 .119 .239 .513 .884 .520 .389 -.008 -.056 .019 .074 .049 .072
b1 .116 .158 .144 1.000 .903 .962 .963 .971 .876 .159 .132 .334 -.178 .957 -.141 -.157 -.194 -.043 -.039
b2 .393 .368 .345 .903 1.000 .841 .870 .841 .895 .555 .367 .273 -.135 .810 -.069 -.064 -.095 .094 .052
niacin .111 .237 .232 .962 .841 1.000 .969 .958 .863 .071 .218 .432 -.049 .924 -.161 -.201 -.225 -.044 -.078
b6 .104 .172 .160 .963 .870 .969 1.000 .974 .882 .130 .160 .367 -.091 .955 -.082 -.157 -.185 .011 -.045
fol98 .071 .128 .119 .971 .841 .958 .974 1.000 .854 .060 .108 .412 -.140 .975 -.072 -.180 -.195 -.077 -.096
b12 .228 .262 .239 .876 .895 .863 .882 .854 1.000 .345 .258 .201 -.085 .850 -.020 -.021 -.038 .061 .026
lact .663 .512 .513 .159 .555 .071 .130 .060 .345 1.000 .625 .024 .019 .004 .072 .150 .139 .253 .187
trypto .784 .834 .884 .132 .367 .218 .160 .108 .258 .625 1.000 .543 .490 -.043 -.042 .015 .038 .085 .069
mn .233 .407 .520 .334 .273 .432 .367 .412 .201 .024 .543 1.000 .402 .226 -.022 -.228 -.150 -.269 -.153
omega .262 .352 .389 -.178 -.135 -.049 -.091 -.140 -.085 .019 .490 .402 1.000 -.234 .089 .122 .143 -.072 .048
folic -.021 .014 -.008 .957 .810 .924 .955 .975 .850 .004 -.043 .226 -.234 1.000 -.060 -.151 -.170 -.057 -.069
post_BMAD -.007 -.056 -.056 -.141 -.069 -.161 -.082 -.072 -.020 .072 -.042 -.022 .089 -.060 1.000 .557 .640 .086 .236
post_ BMD .036 -.017 .074 -.194 -.095 -.225 -.185 -.195 -.038 .139 .038 -.150 .143 -.170 .640 .897 1.000 .235 .580
post_BMC -.013 -.053 .019 -.157 -.064 -.201 -.157 -.180 -.021 .150 .015 -.228 .122 -.151 .557 1.000 .897 .341 .773
SUBTOT_FAT .098 .052 .049 -.043 .094 -.044 .011 -.077 .061 .253 .085 -.269 -.072 -.057 .086 .341 .235 1.000 .577
SUBTOT_LEAN -.022 -.023 .072 -.039 .052 -.078 -.045 -.096 .026 .187 .069 -.153 .048 -.069 .236 .773 .580 .577 1.000
61 
 
 
 
 
b) Total Variance Explained 
Total Variance Explained 
Component 
Initial Eigenvalues Extraction Sums of Squared Loadings 
Total % of Variance Cumulative % Total % of Variance Cumulative % 
1 14.805 42.301 42.301 14.805 42.301 42.301 
2 7.035 20.099 62.400 7.035 20.099 62.400 
3 3.937 11.249 73.649 3.937 11.249 73.649 
4 2.524 7.210 80.859 2.524 7.210 80.859 
5 2.012 5.747 86.607 2.012 5.747 86.607 
6 1.032 2.949 89.556 1.032 2.949 89.556 
7 .894 2.556 92.111    
Extraction Method: Principal Component Analysis. 
 
c) Scree Plot 
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d) Component Matrix 
Component Matrixa 
 
Component 
1 2 3 4 5 6 
b2 .945  .267 -.101   
zn .934 -.245 .162    
b1 .932 -.246 .137 -.107 .136  
b6 .931 -.233   .186  
niacin .920 -.203   .246 .118 
fol98 .912 -.288   .231  
RAE .901 -.341 .193    
iron .892 -.353   .188  
b12 .888  .283    
vitd .878  .335 -.127 -.208 -.110 
retinol .876 -.165 .346    
folic .850 -.414 .173  .195  
vita .847 -.299 -.195 .282 -.245  
bcar .716 -.325 -.378 .397 -.259  
carot .693 -.308 -.404 .410 -.287  
magn .675 .662 -.213  .104  
vitc .633 -.337   .219 .209 
trypto .367 .873 -.133    
sodium .351 .818   .163 .121 
satfat .326 .796  -.150   
ph .575 .783   -.130  
monfat .357 .783  -.172 .108  
k .575 .768     
calc .480 .705 .289  -.345 -.135 
lact .373 .683 .333  -.433 -.182 
omega  .463 -.374 .361 .345  
aofib .552 .318 -.633 .164 .205  
post_ BMD -.215 .236 .606 .532 .323 -.174 
SUBTOT_LEAN  .166 .579 .553  .422 
acar .387 -.112 -.541 .466 -.488  
mn .447 .327 -.516  .497 .117 
post_BMC -.184 .181 .635 .641 .177  
vitak .352  -.469 .548  -.198 
SUBTOT_FAT  .137 .437 .344 -.337 .576 
post_BMAD -.148 .116 .414 .405 .385 -.485 
Extraction Method: Principal Component Analysis.  
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Appendix D 
Simple Linear Regressions  
a) BMD vs Physical Activity 
Correlations 
 log10BMD ANNGymHrs 
Pearson Correlation log10BMD 1.000 .157 
ANNGymHrs .157 1.000 
Sig. (1-tailed) log10BMD . .138 
ANNGymHrs .138 . 
N log10BMD 50 50 
ANNGymHrs 50 50 
 
Model Summaryb 
Model R 
R 
Square 
Adjusted 
R 
Square 
Std. Error of the 
Estimate 
Change Statistics 
Durbin-
Watson 
R Square 
Change 
F 
Change df1 df2 
Sig. F 
Change 
1 .157a .025 .004 .048981717793997 .025 1.211 1 48 .277 .106 
a. Predictors: (Constant), ANNGymHrs 
b. Dependent Variable: log10BMD 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .003 1 .003 1.211 .277b 
Residual .115 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), ANNGymHrs 
 
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 
Correlations 
B Std. Error Beta 
Zero-
order Partial Part 
1 (Constant) -.215 .010  -22.563 .000    
ANNGymHrs .001 .001 .157 1.100 .277 .157 .157 .157 
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a. Dependent Variable: log10BMD 
 
b) BMD vs Beta-carotene  
Correlations 
 log10BMD bcar 
Pearson Correlation log10BMD 1.000 -.337 
bcar -.337 1.000 
Sig. (1-tailed) log10BMD . .008 
bcar .008 . 
N log10BMD 50 50 
bcar 50 50 
 
 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .013 1 .013 6.136 .017b 
Residual .105 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), bcar 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.180 .013  -13.588 .000 
bcar -7.688E-6 .000 -.337 -2.477 .017 
a. Dependent Variable: log10BMD 
b.  
 
 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 
.337a .113 .095 
.046700716768
054 
2.015 
a. Predictors: (Constant), bcar 
b. Dependent Variable: log10BMD 
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c) BMD vs Carotenoids 
Correlations 
 log10BMD carot 
Pearson Correlation log10BMD 1.000 -.344 
carot -.344 1.000 
Sig. (1-tailed) log10BMD . .007 
carot .007 . 
N log10BMD 50 50 
carot 50 50 
 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 
.344a .118 .100 
.046568998693
788 
2.009 
a. Predictors: (Constant), carot 
b. Dependent Variable: log10BMD 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .014 1 .014 6.442 .014b 
Residual .104 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), carot 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.180 .013  -13.819 .000 
carot -4.262E-6 .000 -.344 -2.538 .014 
a. Dependent Variable: log10BMD 
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d) BMD vs vitamin A 
Correlations 
 log10BMD vita 
Pearson Correlation log10BMD 1.000 -.297 
vita -.297 1.000 
Sig. (1-tailed) log10BMD . .018 
vita .018 . 
N log10BMD 50 50 
vita 50 50 
 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 
.297a .088 .069 
.047353568360
617 
2.064 
a. Predictors: (Constant), vita 
b. Dependent Variable: log10BMD 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .010 1 .010 4.653 .036b 
Residual .108 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), vita 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.179 .015  -11.913 .000 
vita -2.831E-6 .000 -.297 -2.157 .036 
a. Dependent Variable: log10BMD 
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e) BMD vs fiber 
Correlations 
 log10BMD aofib 
Pearson Correlation log10BMD 1.000 -.270 
aofib -.270 1.000 
Sig. (1-tailed) log10BMD . .029 
aofib .029 . 
N log10BMD 50 50 
aofib 50 50 
 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 
.270a .073 .054 
.047754525088
430 
1.772 
a. Predictors: (Constant), aofib 
b. Dependent Variable: log10BMD 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .009 1 .009 3.773 .058b 
Residual .109 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), aofib 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.161 .025  -6.390 .000 
aofib -.003 .001 -.270 -1.942 .058 
a. Dependent Variable: log10BMD 
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f) BMD vs vitamin K 
Correlations 
 log10BMD vitak 
Pearson Correlation log10BMD 1.000 -.083 
vitak -.083 1.000 
Sig. (1-tailed) log10BMD . .284 
vitak .284 . 
N log10BMD 50 50 
vitak 50 50 
 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 
.083a .007 -.014 
.049425801297
123 
1.885 
a. Predictors: (Constant), vitak 
b. Dependent Variable: log10BMD 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .001 1 .001 .331 .568b 
Residual .117 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), vitak 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.201 .015  -13.350 .000 
vitak -6.868E-5 .000 -.083 -.575 .568 
a. Dependent Variable: log10BMD 
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g) BMD vs Vitamin D 
Correlations 
 log10BMD VitD 
Pearson Correlation log10BMD 1.000 -.143 
VitD -.143 1.000 
Sig. (1-tailed) log10BMD . .162 
VitD .162 . 
N log10BMD 50 50 
VitD 50 50 
 
Model Summaryb 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate Durbin-Watson 
1 
.143a .020 .000 
.049089580854
508 
1.975 
a. Predictors: (Constant), VitD 
b. Dependent Variable: log10BMD 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .002 1 .002 .995 .324b 
Residual .116 48 .002   
Total .118 49    
a. Dependent Variable: log10BMD 
b. Predictors: (Constant), VitD 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.197 .013  -15.050 .000 
VitD -2.123E-5 .000 -.143 -.997 .324 
a. Dependent Variable: log10BMD 
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Appendix E 
Multiple Regressions 
a) Change in BMD as a function of last Vitamin A measurement 
b) Variables Entered/Removeda 
Model 
Variables 
Entered 
Variables 
Removed Method 
1 gymhrs, 
END_AGE, 
END_VIT_A, 
CHANGE_WTb 
. Enter 
a. Dependent Variable: CHANGE_BMD 
b. All requested variables entered. 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .771a .594 .553 .06685 
a. Predictors: (Constant), gymhrs, END_AGE, END_VIT_A, 
CHANGE_WT 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .255 4 .064 14.282 .000b 
Residual .174 39 .004   
Total .430 43    
a. Dependent Variable: CHANGE_BMD 
c. Predictors: (Constant), gymhrs, END_AGE, END_VIT_A, CHANGE_WT 
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c) Change in BMD as a function of final measurement of biologically active vitamin K 
(Vitamin K- dihydrophylloquinone) 
Variables Entered/Removeda 
Model 
Variables 
Entered 
Variables 
Removed Method 
1 END_BIO_K, 
CHANGE_WT, 
END_D, 
gymhrs, 
END_AGEb 
. Enter 
a. Dependent Variable: LOGBMD 
b. All requested variables entered. 
 
 
 
ANOVAa 
Model Sum of Squares df Mean Square F Sig. 
1 Regression .032 5 .006 3.964 .006b 
Residual .056 35 .002   
Total .088 40    
a. Dependent Variable: LOGBMD 
b. Predictors: (Constant), END_BIO_K, CHANGE_WT, END_D, gymhrs, END_AGE 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -.017 .105  -.161 .873 
END_VIT_A 4.981E-6 .000 .232 2.232 .031 
END_AGE -.006 .010 -.075 -.606 .548 
CHANGE_WT .015 .002 .815 6.422 .000 
gymhrs .001 .002 .063 .610 .545 
a. Dependent Variable: CHANGE_BMD 
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Tests of Between-Subjects Effects 
Dependent Variable:   LOGBMD  
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .032a 5 .006 3.964 .006 
Intercept .030 1 .030 18.703 .000 
END_D 1.938E-8 1 1.938E-8 .000 .997 
CHANGE_WT .009 1 .009 5.793 .022 
gymhrs .001 1 .001 .331 .569 
END_AGE .000 1 .000 .296 .590 
END_BIO_K .007 1 .007 4.183 .048 
Error .056 35 .002     
Total 1.813 41       
Corrected Total .088 40       
a. R Squared = .362 (Adjusted R Squared = .270) 
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Appendix F 
Quartile Analysis  
a) Partial Linear Regression: Change in BMD from when subject entered study to most 
recent DXA scan (CHANGE_BMD) vs most recent reported average intake of vitamin A 
(END_VIT_A). Controlled for change in age (CHANGE_AGE) and change in weight 
(CHANGE_WT) from entering study until most recent data collection, age at most recent 
data collection date (END_AGE) and annual mean hours of physical activity (gymhrs). 
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Estimates 
Dependent Variable:   LOGBMD   
VITAQUART Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1.00 -.213a .013 -.239 -.188 
2.00 -.198a .014 -.225 -.170 
3.00 -.186a .013 -.213 -.159 
4.00 -.233a .013 -.260 -.207 
a. Covariates appearing in the model are evaluated at the following values: 
AGE = 9.4619, BMI = 16.4236, GYMN_HOURS = 5.0362. 
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b) Bone mineral density reported as a function of the difference between vitamin A and 
vitamin D intake. Means are reported by quartile for vitamin A-vitamin D intake and are 
adjusted for age, body mass index, and physical activity. 
 
Tests of Between-Subjects Effects 
Dependent Variable:   LOGBMD   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .020a 6 .003 1.353 .261 
Intercept .044 1 .044 18.321 .000 
AGE .004 1 .004 1.457 .236 
BMI .009 1 .009 3.538 .068 
GYMN_HOURS .000 1 .000 .059 .810 
Quart_RATIO_A_D .004 3 .001 .501 .684 
Error .085 35 .002   
Total 1.926 42    
Corrected Total .104 41    
a. R Squared = .188 (Adjusted R Squared = .049) 
 
Parameter Estimates 
Dependent Variable:   LOGBMD   
Parameter B Std. Error t Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept -.467 .107 -4.367 .000 -.685 -.250 
AGE .008 .007 1.207 .236 -.006 .023 
BMI .011 .006 1.881 .068 -.001 .024 
GYMN_HOURS .000 .002 -.242 .810 -.004 .003 
[Quart_RATIO_A_D=1.00] -.019 .022 -.837 .408 -.064 .027 
[Quart_RATIO_A_D=2.00] .007 .023 .294 .771 -.039 .052 
[Quart_RATIO_A_D=3.00] -.001 .023 -.056 .956 -.048 .046 
[Quart_RATIO_A_D=4.00] 0a . . . . . 
a. This parameter is set to zero because it is redundant. 
 
 
 
 
 
 
76 
 
 
 
Estimates 
Dependent Variable:   LOGBMD   
Quart_RATIO_A_D Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1.00 -.223a .015 -.254 -.193 
2.00 -.198a .016 -.230 -.166 
3.00 -.206a .016 -.238 -.173 
4.00 -.205a .016 -.237 -.172 
a. Covariates appearing in the model are evaluated at the following values: AGE = 
9.4954, BMI = 16.2112, GYMN_HOURS = 4.9423. 
 
 
Appendix G 
Daily Recommended Intakes (DRI) and Tolerable Upper Intake Levels (UL) for Vitamin A and 
Vitamin D for Females Ages 9-13, as Compared to Average Values for Intake in our study 
sample. Quartiles of intake were calculated for each vitamin separately, with the first quartile 
representing the lowest 25% of intake and the fourth quartile representing the highest 25% of 
intake. 
Nutrient DRI: 
Females 
9-13 
UL Average 
Intake: 
First 
Quartile 
Average 
Intake: 
Second 
Quartile 
Average 
Intake: 
Third 
Quartile 
Average 
Intake: 
Fourth 
Quartile 
Vitamin A 2000 IU 5667 IU 5086 IU 7856 IU 10358 IU 17671 IU 
Vitamin D 600 IU 4000 IU 138 IU 364 IU 621 IU 988 IU 
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SARAH K. SKINNER (315) 532-2713 • skskinne@syr.edu 
 
Nutrition Science Education and Honors 
 
Syracuse University              
Syracuse, NY 
Masters of Science, Nutrition Science                 
anticipated May 2016 
 Awarded full graduate assistantship for 2014-2015, and 2015-2016. 
 Cumulative GPA of 4.0. 
 Nutrition Science Graduate Program Marshal for Falk College Convocation, May 2016 
 Nutrition Science and Dietetics Graduate Research Award, 2016 
 
University of Rochester              
Rochester, NY 
Bachelor of Arts in Chemistry                
awarded May 18, 2014 
 Cumulative GPA of 3.74, and Dean’s List for 6 out of 6 Eligible Semesters 
 Graduated Cum Laude, and awarded degree with High Distinction in Chemistry 
 Undergraduate studies provided foundation of knowledge related to chemical and biological understandings of 
life processes, as well as practical skills gained through chemical and medical laboratory research.  
 Science and laboratory studies and research included exploration of concepts related to nutrition at cellular 
levels, how psychosocial issues can impact development and personality, and biochemistry’s involvement in 
medicine and life processes. 
 Selected courses: Chemical Instrumentation Laboratory, Inorganic Chemistry, Physical Chemistry I (Quantum 
Mechanics), Organic Chemistry I with Lab, Organic Chemistry II with Honors Lab, Chemical Concepts, 
Systems, and Practices I & II with Labs, Bioinorganic Chemistry, Mammalian Physiology, Theories of 
Personality and Psychotherapy, Social and Emotional Development, Biological Chemistry, Human Anatomy, 
Intro to Nutrition, and Food Science. 
 
Teaching Experience 
Syracuse University                
Syracuse, NY 
Graduate Assistant August 2014-Present 
 Assist in teaching graduate and upper-level undergraduate classes including nutritional biochemistry, nutrition 
education, community nutrition, and research methods under Dr. Margaret Voss, Dr. Jennifer Wilkins, and Dr. 
Beth Dixon. 
 Hold weekly office hours to aide students in understanding the class material, assist with homework 
assignments, and review for exams. 
 Responsible for grading assignments and exams, proctoring exams, and posting announcements for students on 
Blackboard. 
University of Rochester Rochester, NY 
Organic Chemistry I Laboratory Teaching Assistant September-December 2012 
 Instructed students in proper laboratory techniques and safety measures. 
 Taught students to write professional-grade laboratory reports; critiquing and grading work to strengthen 
scientific writing skills. 
 Facilitated discussions of chemistry behind lab experiments to enhance student understanding of crucial organic 
chemistry topics. 
 Evidenced understanding of proper laboratory usage and abilities to convey knowledge gained in laboratory 
settings to scientific audiences, as well as potential to share this information with audiences of varied levels of 
sophistication. 
 
Research Experience 
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Syracuse University                
Syracuse, NY 
Thesis Research                         
May 2015-Present 
 Guided by Dr. Margaret Voss and Dr. Lynn Brann 
 Examining relationships between dietary intake, bone density, and levels of Vitamin A and vitamin K2 in young 
female gymnasts. In particular, looking at relationship between intake of foods containing menaquinone-4 and 
menaquinone-7 and bone density levels. 
 
 
University of Rochester Medical Center            
Rochester, NY 
Research Assistant for Dr. Lei Xu                 December 
2012- August 2013 
 In Biomedical Genetics Department, supported Dr. Lei Xu investigations of GPR-56 protein in melanoma cells. 
 Performed biochemical analysis techniques such as immunoprecipitation, western blots, and cell and tissue 
culture of MC-1 melanoma cell lines. 
 Planned and implemented independent research entitled: “The Biochemical Characterization of GPR56,” to 
determine ligands and potential components or associated binding partners of complex containing GPR56 in 
various MC-1 melanoma cell lines. 
 Enhanced understanding of medical and scientific research methods and abilities to conduct literature search, 
transform data collected and analyzed into illustrated papers and presentations, and to share findings throughout 
and at completion of the project. 
 
Internships and Volunteer and Leadership Activities  
St. Vincent’s Sports Performance Indianapolis, IN 
Pre-NFL Combine Sports Nutrition Intern January 2015 
 Worked as an intern under registered dietitian Lindsay Langford with athletes preparing for the NFL Combine. 
Worked in collaboration with athletic trainers, physical therapists, and strength and conditioning coaches.  
 Helped personalize and create meal plans to fit each athlete’s needs, assessed hydration status, enforced meal 
plan compliance. 
 Used BodPod to assess athletes’ body composition and determine approximate resting metabolic rate. 
 Shadowed the dietitian in individual consults with clients, and presented to the pre-combine athletes on Sleep 
and Athletic Performance. 
 Conducted literature searches for the dietitian on various topics including halftime nutrition and relationship of 
hydration status to injury. 
 Created a set of nutrition tips to be distributed to USA Track and Field, and used Nutribase Software to enter 
and assess three-day food journals for individual clients. 
 
Syracuse University                
Syracuse, NY 
Cooking on the Hillside Volunteer            September 
2014-December 2014 
 Teach weekly nutrition lesson to inner-city high school students, followed by a cooking class to make a healthy 
meal including foods from the lesson. 
 Help students understand nutrition benefits of foods while teaching them important life skills in the kitchen. 
Nutrition Education and Promotion Association 
 Organization promotes health and nutrition education in the Syracuse University community as well as in the 
city of Syracuse. 
 
University of Rochester              
Rochester, NY 
Lacrosse Camp Counselor and Coach                 
August 2014 
 Worked with 4th-8th graders of all skill levels to improve their passing and catching skills, footwork, and 
offensive and defensive organization, as well as overall knowledge of the game.  
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Member and Captain of Varsity Women’s Lacrosse Team                                                                                      
August 2010-May 2014 
 Two year captain of the team, chosen by coaching staff. 
 Garnish Scholar-Athlete Award Recipient 2013 and IWLCA Academic Honor Roll 2013. 
 
Undergraduate Co-curricular Activities  
University of Rochester              
Rochester, NY 
Peer Career Advisor                
August 2011-May 2014 
 Aided undergraduate and graduate students, enhancing skills required for success in chosen career-fields. 
 Assisted with resume and cover letter writing, internship or job search efforts, and use of varied online tools. 
Goergen Athletic Center Fitness Center Staff and Orientation Team Member             
May 2012-May 2014 
 Greeted and oriented potential, new and existing members and users, ran special training and outreach, and 
addressed questions. 
 
Exercise Nutrition Competencies, Curiosities and Capabilities 
 
 Desire to explore areas of study related to sports nutrition, muscle protein synthesis, and effects of ergogenic 
nutritional supplements and resistance training on body composition and muscle strength.  
 Capacities to conduct laboratory research to assess issues related to chemical and biochemical aspects of 
nutritional and exercise study. 
 Experience teaching and tutoring undergraduate and graduate students in challenging scientific, nutrition-related 
courses. 
 Career goals to become professor and researcher in the field of exercise metabolism and sport nutrition.  
 
 
 
